RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | Respiratory Tract Infections |
|
Accession: | DOID:9008680
|
browse the term
|
Definition: | Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. |
Synonyms: | exact_synonym: | Respiratory Infection, Upper; Respiratory Infections; Respiratory Tract Infection; Upper Respiratory Infections; Upper Respiratory Tract Infections |
| primary_id: | MESH:D012141; RDO:0000329 |
|
|
|
G |
BDNF |
brain derived neurotrophic factor |
|
ISO |
protein:decreased expression:platelet, serum |
RGD |
PMID:17317133 |
RGD:4891069 |
NCBI chr11:27,618,322...27,687,661
Ensembl chr11:27,520,312...27,589,239
|
|
G |
CXCR3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:19039768 |
RGD:4892119 |
NCBI chr X:60,880,759...60,883,355
Ensembl chr X:70,933,160...70,935,756
|
|
G |
FBLN5 |
fibulin 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12189163 |
|
NCBI chr14:72,504,240...72,583,160
Ensembl chr14:91,848,430...91,927,304
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
Severe Acute Respiratory Syndrome |
RGD |
PMID:14633438 |
RGD:4145665 |
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
|
|
G |
IL16 |
interleukin 16 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:14633438 |
RGD:4145665 |
NCBI chr15:60,181,827...60,299,406
Ensembl chr15:79,122,988...79,250,861
|
|
G |
IL4 |
interleukin 4 |
|
ISO |
associated with Asthma |
RGD |
PMID:20573437 |
RGD:5128554 |
NCBI chr 5:128,091,342...128,099,886
Ensembl chr 5:134,253,039...134,261,581
|
|
G |
IL6R |
interleukin 6 receptor |
|
ISO |
DNA:polymorphisms:promoter, exon:-183G>A (human) |
RGD |
PMID:20951753 |
RGD:5128631 |
NCBI chr 1:129,761,914...129,824,386
Ensembl chr 1:133,374,078...133,433,089
|
|
G |
IRF1 |
interferon regulatory factor 1 |
|
ISO |
|
RGD |
PMID:10497103 |
RGD:5128721 |
NCBI chr 5:127,903,887...127,913,843
Ensembl chr 5:134,067,441...134,075,035
|
|
G |
IRF3 |
interferon regulatory factor 3 |
|
ISO |
|
RGD |
PMID:17027894 |
RGD:5128795 |
NCBI chr19:46,674,193...46,680,464
Ensembl chr19:55,593,627...55,599,903
|
|
G |
LEPR |
leptin receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17229951 |
|
NCBI chr 1:64,772,612...64,881,886
Ensembl chr 1:66,693,926...66,764,768
|
|
G |
MBL2 |
mannose binding lectin 2 |
susceptibility |
ISO |
DNA:SNP:exon:p.G54D(rs1800450)(human) DNA:polymorphisms:5' utr, exon:multiple (human) protein:decreased secretion:serum (human) |
RGD |
PMID:15249448 PMID:19169708 PMID:19767106 |
RGD:4889439 RGD:4889453 RGD:8693755 |
NCBI chr10:49,401,364...49,409,328
Ensembl chr10:51,527,758...51,543,432
|
|
G |
MX1 |
MX dynamin like GTPase 1 |
|
ISO |
protein:increased expression:blood (human) |
RGD |
PMID:25542463 |
RGD:126777677 |
NCBI chr21:27,756,768...27,795,307
Ensembl chr21:41,095,928...41,123,019
|
|
G |
RPGR |
retinitis pigmentosa GTPase regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12920075 |
|
NCBI chr X:30,718,669...30,777,671
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
Severe Acute Respiratory Syndrome; protein:increased expression:serum |
RGD |
PMID:14633438 |
RGD:4145665 |
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
|
|
|
G |
CCL17 |
C-C motif chemokine ligand 17 |
|
ISO |
associated with Cystic Fibrosis |
RGD |
PMID:17898016 |
RGD:4145612 |
NCBI chr16:37,678,518...37,689,350
Ensembl chr16:56,819,949...56,822,131
|
|
G |
CCR1 |
C-C motif chemokine receptor 1 |
|
ISO |
|
RGD |
PMID:15951834 |
RGD:5688155 |
NCBI chr 3:46,107,526...46,114,229
Ensembl chr 3:47,214,688...47,215,755
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:10946288 |
RGD:8661731 |
NCBI chr 3:46,255,725...46,263,285
Ensembl chr 3:47,361,124...47,368,312
|
|
G |
CFTR |
CF transmembrane conductance regulator |
|
ISO |
DNA:mutations: : |
RGD |
PMID:11243954 |
RGD:4140482 |
NCBI chr 7:109,449,847...109,633,023
Ensembl chr 7:122,129,798...122,327,864
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
ISO |
|
RGD |
PMID:7743671 |
RGD:8547590 |
NCBI chr19:9,821,402...9,837,021
Ensembl chr19:10,484,414...10,500,605
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
|
RGD |
PMID:8699818 |
RGD:7794730 |
NCBI chr2A:89,273,482...89,284,421
Ensembl chr2A:113,784,854...113,795,801
|
|
G |
LOC100972994 |
HLA class II histocompatibility antigen, DQ beta 1 chain |
susceptibility |
ISO |
associated with cystic fibrosis; DNA:polymorphisms: :DQB1*06:02, DQB1*02:01(human) |
RGD |
PMID:23278646 |
RGD:36049760 |
NCBI chr 6:32,237,395...32,244,201
Ensembl chr 6:33,353,599...33,360,272
|
|
G |
MBL2 |
mannose binding lectin 2 |
susceptibility |
ISO |
Chronic Necrotizing Pulmonary Aspergillosis; DNA:missense mutation:exon:p.R52C (human) DNA:SNP:intron:1011G>A(human) |
RGD |
PMID:11474427 PMID:16487239 |
RGD:4889577 RGD:8693711 |
NCBI chr10:49,401,364...49,409,328
Ensembl chr10:51,527,758...51,543,432
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
|
RGD |
PMID:8699818 |
RGD:7794730 |
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
susceptibility |
ISO |
DNA:snps:5' utr, exon:g.-609G>T rs4149570, g.36A>G rs767455 (human) |
RGD |
PMID:20646338 |
RGD:5131174 |
NCBI chr12:6,457,617...6,470,969
Ensembl chr12:6,374,257...6,387,613
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
severity |
ISO |
DNA:snp:exon:c.1236C>T (human) |
RGD |
PMID:24040855 |
RGD:8657076 |
NCBI chr 7:79,497,536...79,706,277
Ensembl chr 7:93,147,950...93,243,238
|
|
G |
ACE |
angiotensin I converting enzyme |
no_association |
ISO |
DNA:deletion:intron:IVS16+1464-1751del (human) |
RGD |
PMID:15112973 |
RGD:8142345 |
NCBI chr17:57,556,294...57,577,294
Ensembl chr17:62,702,341...62,733,853
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
|
ISO |
mRNA, protein:increased expression:nasal mucosa (rat) |
RGD |
PMID:15362690 |
RGD:11522724 |
NCBI chr18:56,481,212...56,679,012
Ensembl chr18:59,802,443...59,992,100
|
|
G |
CAT |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29028686 |
|
NCBI chr11:34,413,253...34,446,831
Ensembl chr11:34,289,603...34,323,160
|
|
G |
CCL26 |
C-C motif chemokine ligand 26 |
|
ISO |
protein:increased expression:oronasal secretion (human) |
RGD |
PMID:23883806 |
RGD:7364793 |
NCBI chr 7:68,230,804...68,251,369
Ensembl chr 7:82,221,846...82,242,874
|
|
G |
CD40 |
CD40 molecule |
|
ISO |
protein:increased expression:lymphocyte |
RGD |
PMID:19086656 |
RGD:8547782 |
NCBI chr20:42,455,711...42,467,139
Ensembl chr20:43,541,619...43,552,994
|
|
G |
CD40LG |
CD40 ligand |
|
ISO |
protein:increased expression:lymphocyte |
RGD |
PMID:19086656 |
RGD:8547782 |
NCBI chr X:125,776,138...125,788,820
Ensembl chr X:136,042,849...136,058,202
|
|
G |
CLDN3 |
claudin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33441633 |
|
Ensembl chr 7:80,924,731...80,925,393
|
|
G |
CLDN7 |
claudin 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33441633 |
|
NCBI chr17:7,289,766...7,292,433
Ensembl chr17:7,277,313...7,281,859
|
|
G |
CTLA4 |
cytotoxic T-lymphocyte associated protein 4 |
treatment |
ISO |
|
RGD |
PMID:10436391 |
RGD:11344920 |
NCBI chr2B:91,054,917...91,106,234
Ensembl chr2B:209,239,417...209,244,498
|
|
G |
F2 |
coagulation factor II, thrombin |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:21711961 |
RGD:5147783 |
NCBI chr11:46,669,925...46,690,391
Ensembl chr11:47,227,891...47,249,157
|
|
G |
FCGR3A |
Fc gamma receptor IIIa |
susceptibility |
ISO |
DNA:polymorphism:exon:p.F158V(rs396991)(human) |
RGD |
PMID:18199088 |
RGD:5508449 |
NCBI chr 1:137,027,943...137,036,738
|
|
G |
GRIA1 |
glutamate ionotropic receptor AMPA type subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34624383 |
|
NCBI chr 5:148,879,996...149,206,914
Ensembl chr 5:154,879,080...155,204,660
|
|
G |
GRIA2 |
glutamate ionotropic receptor AMPA type subunit 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34624383 |
|
NCBI chr 4:149,566,563...149,712,135
Ensembl chr 4:161,380,933...161,524,376
|
|
G |
HMOX1 |
heme oxygenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:36127783 |
|
NCBI chr22:16,388,368...16,401,289
Ensembl chr22:34,230,825...34,244,063
|
|
G |
HRH1 |
histamine receptor H1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23333628 |
|
NCBI chr 3:11,074,451...11,199,871
Ensembl chr 3:11,541,294...11,542,757
|
|
G |
IFNG |
interferon gamma |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism associated with Asthma |
RGD CTD |
PMID:12787306 PMID:18510219 PMID:29871060 |
RGD:10755770 RGD:7829803 |
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
|
|
G |
IL10 |
interleukin 10 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:23253209 PMID:23883806 PMID:36127783 |
RGD:7364793 RGD:7364818 |
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
|
|
G |
IL13 |
interleukin 13 |
susceptibility no_association |
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNPs:promoter, cds:-1112C>T, p.R130Q (rs1800925, rs20541) (human) |
OMIM CTD RGD |
PMID:12928861 |
RGD:8549516 |
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
|
|
G |
IL13RA2 |
interleukin 13 receptor subunit alpha 2 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21462799 |
RGD:8549521 |
NCBI chr X:104,092,993...104,146,062
Ensembl chr X:114,597,077...114,635,253
|
|
G |
IL17A |
interleukin 17A |
susceptibility |
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) DNA:snp:promoter:c.-444A>G (human) |
RGD |
PMID:21535180 PMID:22507625 |
RGD:5147409 RGD:9068429 |
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
|
|
G |
IL18 |
interleukin 18 |
no_association severity |
ISO |
DNA:SNP:promoter:-140C>G (rs360721) (human) DNA:SNP:promoter:-137G>C (rs187238) (human) |
RGD |
PMID:22840759 |
RGD:8655914 |
NCBI chr11:107,024,376...107,045,194
Ensembl chr11:110,867,586...110,888,371
|
|
G |
IL1B |
interleukin 1 beta |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:7750009 |
RGD:7401199 |
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
|
|
G |
IL2 |
interleukin 2 |
|
ISO |
|
RGD |
PMID:12592663 |
RGD:8662963 |
NCBI chr 4:114,637,328...114,642,586
Ensembl chr 4:125,782,563...125,787,984
|
|
G |
IL4 |
interleukin 4 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:8908280 PMID:9893928 PMID:14653048 PMID:24620662 PMID:36127783 |
RGD:11522769 RGD:7829796 RGD:7829802 RGD:7829827 |
NCBI chr 5:128,091,342...128,099,886
Ensembl chr 5:134,253,039...134,261,581
|
|
G |
IL5 |
interleukin 5 |
treatment |
ISO |
|
RGD |
PMID:23934070 PMID:24620662 |
RGD:11354976 RGD:11522769 |
NCBI chr 5:127,955,377...127,961,726
Ensembl chr 5:134,119,608...134,121,675
|
|
G |
ITGB2 |
integrin subunit beta 2 |
treatment |
ISO |
|
RGD |
PMID:12046991 |
RGD:9698435 |
NCBI chr21:31,181,228...31,216,033
Ensembl chr21:44,470,999...44,505,963
|
|
G |
MRC1 |
mannose receptor C-type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:36127783 |
|
NCBI chr10:18,128,280...18,230,438
Ensembl chr10:18,398,310...18,500,367
|
|
G |
MUC1 |
mucin 1, cell surface associated |
severity |
ISO |
mRNA,protein:decreased expression:nasal mucosa |
RGD |
PMID:31425778 |
RGD:127345100 |
NCBI chr 1:130,533,508...130,537,866
Ensembl chr 1:134,141,969...134,145,850
|
|
G |
MUC5AC |
mucin 5AC, oligomeric mucus/gel-forming |
|
ISO |
mRNA, protein:increased expression:nasal cavity epithelium |
RGD |
PMID:22972875 |
RGD:7364746 |
NCBI chr11:1,191,223...1,234,373
|
|
G |
NOD2 |
nucleotide binding oligomerization domain containing 2 |
|
ISO |
mRNA:increased expression:nasal mucosa (human) |
RGD |
PMID:23858718 |
RGD:8547523 |
NCBI chr16:30,955,976...30,995,451
Ensembl chr16:49,837,891...49,873,773
|
|
G |
OCLN |
occludin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33441633 |
|
NCBI chr 5:44,447,230...44,509,637
Ensembl chr 5:46,023,437...46,069,342
|
|
G |
PON1 |
paraoxonase 1 |
severity |
ISO |
protein:decreased activity:plasma (human) |
RGD |
PMID:23406590 |
RGD:8547583 |
NCBI chr 7:87,253,476...87,279,650
Ensembl chr 7:100,841,286...100,867,493
|
|
G |
PRKG1 |
protein kinase cGMP-dependent 1 |
|
ISO |
protein:increased expression:nasal cavity epithelium |
RGD |
PMID:24012634 |
RGD:7775060 |
NCBI chr10:47,642,312...48,935,188
Ensembl chr10:49,779,211...51,064,882
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16979129 |
|
NCBI chr 1:162,205,534...162,214,130
Ensembl chr 1:166,355,845...166,364,519
|
|
G |
SCGB1A1 |
secretoglobin family 1A member 1 |
|
ISO |
mRNA:decreased expression:nasal mucosa, lung |
RGD |
PMID:17882576 |
RGD:5144135 |
NCBI chr11:57,774,560...57,780,334
Ensembl chr11:61,133,649...61,137,873
|
|
G |
SCGB3A2 |
secretoglobin family 3A member 2 |
susceptibility |
ISO |
DNA:SNP: :rs7726552 (human) |
RGD |
PMID:21410962 |
RGD:5144225 |
NCBI chr 5:143,319,941...143,323,625
Ensembl chr 5:149,329,201...149,333,003
|
|
G |
SERPINE1 |
serpin family E member 1 |
|
ISO |
mRNA:increased expression:nasal mucosa (mouse) |
RGD |
PMID:21339035 |
RGD:8547809 |
NCBI chr 7:93,267,517...93,279,728
Ensembl chr 7:106,510,130...106,518,450
|
|
G |
TACR1 |
tachykinin receptor 1 |
|
ISO |
mRNA:increased expression:nasal mucosa |
RGD |
PMID:12768696 |
RGD:5147835 |
NCBI chr2A:75,111,339...75,267,320
Ensembl chr2A:76,614,478...76,771,018
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
treatment |
ISO |
|
RGD |
PMID:31368266 |
RGD:14995445 |
NCBI chr19:38,324,009...38,347,003
Ensembl chr19:46,831,659...46,852,973
|
|
G |
TLR2 |
toll like receptor 2 |
severity |
ISO |
mRNA:decreased expression:nasal mucosa: DNA:polymorphism:cds:p.R753Q(human) protein:increased expression:neutrophil: |
RGD |
PMID:18219831 PMID:18381801 PMID:22402138 PMID:22555057 |
RGD:7800732 RGD:7800742 RGD:8552972 RGD:8552993 |
NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331
|
|
G |
TLR4 |
toll like receptor 4 |
susceptibility no_association treatment severity |
ISO |
protein:increased expression:nasal lavage,leukocyte, bone marrow: DNA:SNP: :rs1927911(human) protein:decreased expression:nasal mucosa: DNA:polymorphism: :4216G>C(human) DNA:polymorphism:cds:p.D299G(human) |
RGD |
PMID:17069098 PMID:19763595 PMID:22402138 PMID:22555057 PMID:22577387 PMID:23639307 More...
|
RGD:4145354 RGD:7800732 RGD:7800736 RGD:7800738 RGD:7800740 RGD:8552993 |
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
|
|
|
G |
CYP2C19 |
cytochrome P450 family 2 subfamily C member 19 |
treatment |
ISO |
associated with Eosinophilic Esophagitis; DNA:polymorphisms:: |
RGD |
PMID:26416193 |
RGD:11352743 |
NCBI chr10:91,375,255...91,465,215
Ensembl chr10:94,884,472...94,970,065
|
|
G |
IL3 |
interleukin 3 |
susceptibility |
ISO |
DNA:SNP: :rs40401(human) |
RGD |
PMID:23953855 |
RGD:13506915 |
NCBI chr 5:127,483,843...127,486,388
Ensembl chr 5:133,647,667...133,650,213
|
|
|
G |
AGER |
advanced glycosylation end-product specific receptor |
|
ISO |
DNA:SNP:promoter:-374T>A (human) |
RGD |
PMID:22114731 |
RGD:8695981 |
NCBI chr 6:31,828,363...31,831,981
Ensembl chr 6:32,708,251...32,711,641
|
|
G |
CCL19 |
C-C motif chemokine ligand 19 |
|
ISO |
associated with Neutropenia;mRNA:increased expression:lung |
RGD |
PMID:19783686 |
RGD:5130908 |
NCBI chr 9:34,525,820...34,527,628
Ensembl chr 9:35,334,353...35,336,108
|
|
G |
CCR7 |
C-C motif chemokine receptor 7 |
|
ISO |
associated with Neutropenia |
RGD |
PMID:19783686 |
RGD:5130908 |
NCBI chr17:16,720,236...16,731,955
Ensembl chr17:16,949,119...16,956,370
|
|
G |
CD209 |
CD209 molecule |
|
ISO |
|
RGD |
PMID:21381282 |
RGD:5131183 |
NCBI chr19:7,042,033...7,047,350
|
|
G |
CFTR |
CF transmembrane conductance regulator |
severity |
ISO |
|
RGD |
PMID:22135344 |
RGD:35673332 |
NCBI chr 7:109,449,847...109,633,023
Ensembl chr 7:122,129,798...122,327,864
|
|
G |
CLEC1A |
C-type lectin domain family 1 member A |
susceptibility |
ISO |
ClinVar Annotator: match by term: Aspergillosis, susceptibility to |
OMIM ClinVar |
PMID:25741868 PMID:29489751 |
|
NCBI chr12:10,115,664...10,145,766
Ensembl chr12:10,359,392...10,418,806
|
|
G |
CLEC7A |
C-type lectin domain containing 7A |
susceptibility |
ISO |
ClinVar Annotator: match by term: CLEC7A-related condition |
ClinVar OMIM |
PMID:19864674 PMID:20807886 PMID:24033266 PMID:25741868 PMID:28492532 |
|
NCBI chr12:10,161,780...10,174,943
Ensembl chr12:10,410,384...10,425,452
|
|
G |
CRP |
C-reactive protein |
treatment |
ISO |
|
RGD |
PMID:20879853 |
RGD:9495929 |
NCBI chr 1:135,062,102...135,064,402
|
|
G |
IL15 |
interleukin 15 |
|
ISO |
DNA:polymorphism (human) |
RGD |
PMID:16893395 |
RGD:4981337 |
NCBI chr 4:133,693,995...134,115,470
Ensembl chr 4:145,402,111...145,416,622
|
|
G |
MBL2 |
mannose binding lectin 2 |
susceptibility |
ISO |
|
RGD |
PMID:20064561 |
RGD:8694071 |
NCBI chr10:49,401,364...49,409,328
Ensembl chr10:51,527,758...51,543,432
|
|
G |
S100B |
S100 calcium binding protein B |
|
ISO |
DNA:SNP: :427C>T (human) |
RGD |
PMID:22114731 |
RGD:8695981 |
NCBI chr21:33,063,845...33,070,073
Ensembl chr21:46,197,750...46,203,953
|
|
G |
TLR1 |
toll like receptor 1 |
susceptibility |
ISO |
DNA:SNPs: :p.R80T, p.N248S (human) |
RGD |
PMID:16461792 |
RGD:4889535 |
NCBI chr 4:33,119,485...33,133,541
Ensembl chr 4:38,979,006...38,981,366
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:19781388 |
RGD:4145322 |
NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331
|
|
G |
TLR6 |
toll like receptor 6 |
susceptibility |
ISO |
DNA:SNP: :p.S249P (human) |
RGD |
PMID:16461792 |
RGD:4889535 |
NCBI chr 4:33,153,151...33,174,053
Ensembl chr 4:39,009,103...39,011,490
|
|
|
G |
ACE |
angiotensin I converting enzyme |
|
ISO |
associated with Cerebrovascular Accident |
RGD |
PMID:14990394 |
RGD:4140926 |
NCBI chr17:57,556,294...57,577,294
Ensembl chr17:62,702,341...62,733,853
|
|
G |
EDN1 |
endothelin 1 |
|
ISO |
protein:increased secretion:plasma (rat) |
RGD |
PMID:19262391 |
RGD:4145069 |
NCBI chr 6:12,076,312...12,142,861
Ensembl chr 6:12,462,718...12,503,545
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
protein:increased expression:Bronchoalveolar Lavage Fluid |
RGD |
PMID:18042282 |
RGD:4142854 |
NCBI chr2A:89,273,482...89,284,421
Ensembl chr2A:113,784,854...113,795,801
|
|
G |
LOC100974886 |
uncharacterized LOC100974886 |
|
ISO |
|
RGD |
PMID:19515386 |
RGD:4891456 |
NCBI chr 4:50,092,989...50,095,541
Ensembl chr 4:55,925,562...55,986,555
|
|
G |
LOC100976904 |
growth-regulated alpha protein |
|
ISO |
|
RGD |
PMID:19515386 |
RGD:4891456 |
NCBI chr 4:50,325,248...50,327,165
Ensembl chr 4:56,153,899...56,159,474
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15607125 |
|
NCBI chr17:28,984,295...29,021,516
Ensembl chr17:29,471,510...29,617,093
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
protein:increased expression:Bronchoalveolar Lavage Fluid |
RGD |
PMID:18042282 |
RGD:4142854 |
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
|
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
severity |
ISO |
protein:increased expression:nasal mucus (human) |
RGD |
PMID:24211414 |
RGD:40925940 |
NCBI chr 4:50,452,857...50,456,015
Ensembl chr 4:56,286,708...56,288,083
|
|
G |
MARCO |
macrophage receptor with collagenous structure |
disease_progression |
ISO |
association with Cryptococcal neoformans infection. |
RGD |
PMID:28298522 |
RGD:41412191 |
NCBI chr2B:5,896,433...5,940,284
Ensembl chr2B:119,475,677...119,520,385
|
|
|
G |
ABCC1 |
ATP binding cassette subfamily C member 1 (ABCC1 blood group) |
|
ISO |
|
RGD |
PMID:11238654 |
RGD:5128828 |
|
|
G |
ACE2 |
angiotensin converting enzyme 2 |
|
ISO |
associated with Pseudomonas Infections;mRNA, protein:altered expression, altered activity:lung (mouse) |
RGD |
PMID:31645418 |
RGD:40818279 |
NCBI chr X:8,189,267...8,229,415
Ensembl chr X:15,470,896...15,510,891
|
|
G |
AGER |
advanced glycosylation end-product specific receptor |
severity |
ISO |
|
RGD |
PMID:21629785 |
RGD:6767559 |
NCBI chr 6:31,828,363...31,831,981
Ensembl chr 6:32,708,251...32,711,641
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:16014897 |
RGD:5129508 |
NCBI chr19:5,708,211...5,753,178
Ensembl chr19:6,629,287...6,674,699
|
|
G |
C3AR1 |
complement C3a receptor 1 |
|
ISO |
|
RGD |
PMID:16461429 |
RGD:5129690 |
NCBI chr12:8,178,064...8,186,206
Ensembl chr12:8,220,933...8,222,381
|
|
G |
C5 |
complement C5 |
|
ISO |
|
RGD |
PMID:17975174 |
RGD:5129707 |
NCBI chr 9:92,069,574...92,202,513
Ensembl chr 9:120,426,354...120,523,856
|
|
G |
CAT |
catalase |
|
ISO |
protein:decreased expression:lung, plasma |
RGD |
PMID:19842849 |
RGD:5130748 |
NCBI chr11:34,413,253...34,446,831
Ensembl chr11:34,289,603...34,323,160
|
|
G |
CCL19 |
C-C motif chemokine ligand 19 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:20176793 |
RGD:5130918 |
NCBI chr 9:34,525,820...34,527,628
Ensembl chr 9:35,334,353...35,336,108
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
|
ISO |
|
RGD |
PMID:20042590 |
RGD:4891443 |
NCBI chr17:22,528,154...22,530,091
Ensembl chr17:22,820,890...22,823,384
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:20042590 |
RGD:4891443 |
NCBI chr 3:46,255,725...46,263,285
Ensembl chr 3:47,361,124...47,368,312
|
|
G |
CCR7 |
C-C motif chemokine receptor 7 |
|
ISO |
|
RGD |
PMID:20176793 |
RGD:5130918 |
NCBI chr17:16,720,236...16,731,955
Ensembl chr17:16,949,119...16,956,370
|
|
G |
CD14 |
CD14 molecule |
|
ISO |
|
RGD |
PMID:16210672 |
RGD:4144197 |
NCBI chr 5:135,996,265...135,997,909
Ensembl chr 5:142,113,082...142,118,966
|
|
G |
CD40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:20102413 |
RGD:5132268 |
NCBI chr20:42,455,711...42,467,139
Ensembl chr20:43,541,619...43,552,994
|
|
G |
CD80 |
CD80 molecule |
|
ISO |
|
RGD |
PMID:20949109 |
RGD:4892562 |
NCBI chr 3:116,646,590...116,683,725
Ensembl chr 3:123,559,559...123,594,870
|
|
G |
CHUK |
component of inhibitor of nuclear factor kappa B kinase complex |
|
ISO |
|
RGD |
PMID:18643924 |
RGD:5133701 |
NCBI chr10:96,794,228...96,835,449
Ensembl chr10:100,280,490...100,316,918
|
|
G |
CSF3 |
colony stimulating factor 3 |
disease_progression treatment |
ISO |
associated with Peritonitis; |
RGD |
PMID:12352049 PMID:21373266 |
RGD:11039437 RGD:5133733 |
NCBI chr17:17,271,074...17,273,493
Ensembl chr17:17,491,276...17,493,729
|
|
G |
CSF3R |
colony stimulating factor 3 receptor |
disease_progression |
ISO |
|
RGD |
PMID:17185469 |
RGD:5133739 |
NCBI chr 1:35,730,678...35,747,939
Ensembl chr 1:36,897,153...36,910,612
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
severity |
ISO |
|
RGD |
PMID:15618188 PMID:16299319 |
RGD:5135458 RGD:5135459 |
NCBI chr 4:48,182,355...48,184,733
Ensembl chr 4:54,020,204...54,022,606
|
|
G |
CXCL11 |
C-X-C motif chemokine ligand 11 |
|
ISO |
|
RGD |
PMID:15618188 |
RGD:5135459 |
NCBI chr 4:48,169,954...48,172,455
Ensembl chr 4:54,007,818...54,010,336
|
|
G |
CXCL6 |
C-X-C motif chemokine ligand 6 |
|
ISO |
|
RGD |
PMID:19846873 |
RGD:4145490 |
NCBI chr 4:50,357,643...50,359,822
Ensembl chr 4:56,189,961...56,192,402
|
|
G |
CXCL9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
|
RGD |
PMID:15618188 |
RGD:5135459 |
NCBI chr 4:48,198,478...48,204,658
Ensembl chr 4:54,036,342...54,042,502
|
|
G |
CXCR3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:15618188 |
RGD:5135459 |
NCBI chr X:60,880,759...60,883,355
Ensembl chr X:70,933,160...70,935,756
|
|
G |
CYP2J2 |
cytochrome P450 family 2 subfamily J member 2 |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:14766666 |
RGD:1625385 |
NCBI chr 1:59,151,079...59,184,625
Ensembl chr 1:60,856,269...60,889,810
|
|
G |
F2 |
coagulation factor II, thrombin |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:21897338 |
RGD:6893486 |
NCBI chr11:46,669,925...46,690,391
Ensembl chr11:47,227,891...47,249,157
|
|
G |
FOXP3 |
forkhead box P3 |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr X:41,550,462...41,567,492
Ensembl chr X:49,402,652...49,417,029
|
|
G |
GP1BA |
glycoprotein Ib platelet subunit alpha |
exacerbates |
ISO |
associated with Escherichia Coli Infections |
RGD |
PMID:27845343 |
RGD:42722624 |
NCBI chr17:4,980,083...4,983,219
|
|
G |
GRK2 |
G protein-coupled receptor kinase 2 |
|
ISO |
mRNA:decreased expression:polymorphonuclear leukocyte |
RGD |
PMID:24465168 |
RGD:126848796 |
NCBI chr11:62,624,647...62,644,846
Ensembl chr11:65,939,164...65,959,066
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
ISO |
protein:increased expression:lung (mouse) |
RGD |
PMID:19846873 |
RGD:4145490 |
NCBI chr19:9,821,402...9,837,021
Ensembl chr19:10,484,414...10,500,605
|
|
G |
IFNAR1 |
interferon alpha and beta receptor subunit 1 |
severity |
ISO |
|
RGD |
PMID:19487810 |
RGD:5490274 |
NCBI chr21:19,683,496...19,719,034
Ensembl chr21:33,058,396...33,093,824
|
|
G |
IFNG |
interferon gamma |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
|
|
G |
IL10 |
interleukin 10 |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
|
|
G |
IL15 |
interleukin 15 |
|
ISO |
|
RGD |
PMID:17911627 |
RGD:5000754 |
NCBI chr 4:133,693,995...134,115,470
Ensembl chr 4:145,402,111...145,416,622
|
|
G |
IL17A |
interleukin 17A |
severity |
ISO |
|
RGD |
PMID:18802100 PMID:25398094 |
RGD:38501102 RGD:4889153 |
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
|
|
G |
IL18 |
interleukin 18 |
|
ISO |
|
RGD |
PMID:17664259 |
RGD:4889913 |
NCBI chr11:107,024,376...107,045,194
Ensembl chr11:110,867,586...110,888,371
|
|
G |
IL1B |
interleukin 1 beta |
treatment severity |
ISO |
associated with Agranulocytosis |
RGD |
PMID:7546648 PMID:18596024 PMID:25398094 |
RGD:10755357 RGD:38501102 RGD:4143205 |
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
|
|
G |
IL1RL1 |
interleukin 1 receptor like 1 |
treatment |
ISO |
associated with Sepsis associated with Acinetobacter infectious disease |
RGD |
PMID:20959556 PMID:29508184 |
RGD:40818077 RGD:5144223 |
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
|
RGD |
PMID:18322242 PMID:18596024 |
RGD:4143205 RGD:4143206 |
NCBI chr2A:88,991,646...89,008,013
Ensembl chr2A:114,061,182...114,078,839
|
|
G |
IL6 |
interleukin 6 |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr 7:23,415,922...23,420,767
|
|
G |
IRAK3 |
interleukin 1 receptor associated kinase 3 |
|
ISO |
|
RGD |
PMID:20439918 PMID:28120642 |
RGD:34888234 RGD:36049799 |
NCBI chr12:22,661,613...22,721,203
Ensembl chr12:23,168,346...23,227,148
|
|
G |
IRF1 |
interferon regulatory factor 1 |
|
ISO |
|
RGD |
PMID:11854220 |
RGD:5128725 |
NCBI chr 5:127,903,887...127,913,843
Ensembl chr 5:134,067,441...134,075,035
|
|
G |
IRF3 |
interferon regulatory factor 3 |
|
ISO |
|
RGD |
PMID:20720199 |
RGD:4891951 |
NCBI chr19:46,674,193...46,680,464
Ensembl chr19:55,593,627...55,599,903
|
|
G |
ITGB3 |
integrin subunit beta 3 |
|
ISO |
protein:increased expression:lung, neutrophil |
RGD |
PMID:15114484 |
RGD:4993468 |
NCBI chr17:10,134,450...10,194,596
Ensembl chr17:10,353,111...10,392,382
|
|
G |
LEP |
leptin |
|
ISO |
|
RGD |
PMID:11937559 |
RGD:5128871 |
NCBI chr 7:120,230,896...120,248,602
Ensembl chr 7:132,885,011...132,901,519
|
|
G |
LOC100974886 |
uncharacterized LOC100974886 |
severity |
ISO |
|
RGD |
PMID:11052817 PMID:19239431 PMID:21723409 |
RGD:5135062 RGD:5135065 RGD:5135234 |
NCBI chr 4:50,092,989...50,095,541
Ensembl chr 4:55,925,562...55,986,555
|
|
G |
LOC100976904 |
growth-regulated alpha protein |
|
ISO |
|
RGD |
PMID:11052817 PMID:21723409 |
RGD:5135062 RGD:5135234 |
NCBI chr 4:50,325,248...50,327,165
Ensembl chr 4:56,153,899...56,159,474
|
|
G |
LOC103783265 |
pulmonary surfactant-associated protein A1 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:12169586 |
RGD:4143464 |
NCBI chr10:76,571,312...76,575,820
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
severity |
ISO |
associated with Escherichia Coli Infections |
RGD |
PMID:22514650 |
RGD:150340681 |
NCBI chr10:45,806,748...45,936,362
|
|
G |
MBL2 |
mannose binding lectin 2 |
|
ISO |
Legionella Pneumonia; DNA:mutations:5' utr, exon:multiple (human) |
RGD |
PMID:18641104 |
RGD:4889477 |
NCBI chr10:49,401,364...49,409,328
Ensembl chr10:51,527,758...51,543,432
|
|
G |
MC1R |
melanocortin 1 receptor |
|
ISO |
|
RGD |
PMID:18304533 |
RGD:5687324 |
NCBI chr16:70,676,447...70,697,636
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:bronchoalveolar lavage fluid |
RGD |
PMID:17202364 PMID:19535150 |
RGD:5129533 RGD:5130727 |
NCBI chr20:42,346,305...42,354,018
Ensembl chr20:43,432,389...43,440,129
|
|
G |
MPO |
myeloperoxidase |
|
ISO |
protein:increased activity:bronchoalveolar lavage Fluid: |
RGD |
PMID:11269653 |
RGD:5130992 |
NCBI chr17:52,333,882...52,357,838
Ensembl chr17:57,201,073...57,212,111
|
|
G |
NOD1 |
nucleotide binding oligomerization domain containing 1 |
|
ISO |
|
RGD |
PMID:19360122 |
RGD:5131449 |
NCBI chr 7:31,060,245...31,109,012
Ensembl chr 7:31,182,275...31,208,742
|
|
G |
NOD2 |
nucleotide binding oligomerization domain containing 2 |
|
ISO |
|
RGD |
PMID:19360122 |
RGD:5131449 |
NCBI chr16:30,955,976...30,995,451
Ensembl chr16:49,837,891...49,873,773
|
|
G |
PDPN |
podoplanin |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:7864138 |
RGD:2292375 |
NCBI chr 1:12,728,569...12,759,781
Ensembl chr 1:13,728,233...13,759,584
|
|
G |
PECAM1 |
platelet and endothelial cell adhesion molecule 1 |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:12524254 |
RGD:724645 |
NCBI chr17:58,417,134...58,526,409
Ensembl chr17:63,511,784...63,579,067
|
|
G |
PGF |
placental growth factor |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:16702604 |
RGD:6483601 |
NCBI chr14:55,494,152...55,508,066
Ensembl chr14:74,338,976...74,352,964
|
|
G |
PTEN |
phosphatase and tensin homolog |
ameliorates |
ISO |
myeloid knockout |
RGD |
PMID:21527775 |
RGD:127285594 |
NCBI chr10:84,587,841...84,689,043
Ensembl chr10:88,093,539...88,194,605
|
|
G |
RIPK3 |
receptor interacting serine/threonine kinase 3 |
ameliorates |
ISO |
|
RGD |
PMID:28387756 |
RGD:127229944 |
NCBI chr14:5,112,512...5,116,486
Ensembl chr14:23,235,796...23,239,821
|
|
G |
RORC |
RAR related orphan receptor C |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr 1:127,164,725...127,190,479
Ensembl chr 1:130,808,705...130,834,490
|
|
G |
SERPINE1 |
serpin family E member 1 |
severity |
ISO |
|
RGD |
PMID:17032919 |
RGD:4144840 |
NCBI chr 7:93,267,517...93,279,728
Ensembl chr 7:106,510,130...106,518,450
|
|
G |
SFTPB |
surfactant protein B |
|
ISO |
associated with Cystic Fibrosis;protein:increased expression:lung |
RGD |
PMID:12169586 PMID:15271694 |
RGD:4143403 RGD:4143464 |
NCBI chr2A:85,708,485...85,718,120
Ensembl chr2A:87,257,244...87,268,332
|
|
G |
SFTPC |
surfactant protein C |
|
ISO |
|
RGD |
PMID:12169586 PMID:18566429 |
RGD:4143464 RGD:4144114 |
NCBI chr 8:21,402,060...21,409,438
Ensembl chr 8:18,345,940...18,348,764
|
|
G |
SFTPD |
surfactant protein D |
|
ISO |
protein:increased expression:lung associated with Cystic Fibrosis;protein:decreased expression:lung |
RGD |
PMID:12169586 PMID:15271694 |
RGD:4143403 RGD:4143464 |
NCBI chr10:76,275,147...76,318,952
Ensembl chr10:78,965,252...78,974,181
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
|
ISO |
|
RGD |
PMID:18192501 |
RGD:6892945 |
NCBI chr17:14,928,689...15,003,644
Ensembl chr17:15,152,358...15,227,067
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr19:38,324,009...38,347,003
Ensembl chr19:46,831,659...46,852,973
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
|
RGD |
PMID:18768871 PMID:19844782 |
RGD:4145337 RGD:4889533 |
NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331
|
|
G |
TLR4 |
toll like receptor 4 |
|
ISO |
|
RGD |
PMID:16210672 PMID:20650991 |
RGD:4144172 RGD:4144197 |
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
|
|
G |
TLR5 |
toll like receptor 5 |
|
ISO |
|
RGD |
PMID:19801452 |
RGD:5129503 |
NCBI chr 1:198,787,046...198,819,537
Ensembl chr 1:203,798,767...203,801,343
|
|
G |
TLR6 |
toll like receptor 6 |
|
ISO |
|
RGD |
PMID:19844782 |
RGD:4889533 |
NCBI chr 4:33,153,151...33,174,053
Ensembl chr 4:39,009,103...39,011,490
|
|
G |
TNF |
tumor necrosis factor |
severity treatment disease_progression |
ISO |
associated with Agranulocytosis |
RGD |
PMID:7546648 PMID:9310939 PMID:10650487 PMID:12958055 |
RGD:10449451 RGD:10450564 RGD:10755357 RGD:4143476 |
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
|
ISO |
protein:increased expression:serum (mouse) |
RGD |
PMID:19842848 |
RGD:5131429 |
NCBI chr12:6,457,617...6,470,969
Ensembl chr12:6,374,257...6,387,613
|
|
G |
TNFRSF1B |
TNF receptor superfamily member 1B |
|
ISO |
protein:increased expression:serum (mouse) |
RGD |
PMID:19842848 |
RGD:5131429 |
NCBI chr 1:10,915,743...10,957,765
Ensembl chr 1:12,130,663...12,172,646
|
|
G |
TREM1 |
triggering receptor expressed on myeloid cells 1 |
severity ameliorates |
ISO |
|
RGD |
PMID:16960786 PMID:22996209 PMID:24465168 |
RGD:126848796 RGD:126925987 RGD:127229902 |
NCBI chr 6:40,861,283...40,874,446
Ensembl chr 6:42,163,337...42,183,091
|
|
G |
ZC3H12A |
zinc finger CCCH-type containing 12A |
|
ISO |
associated with Pseudomonas Infections |
RGD |
PMID:29695841 |
RGD:39938967 |
NCBI chr 1:36,743,341...36,753,261
Ensembl chr 1:38,093,917...38,103,556
|
|
|
G |
ADRB2 |
adrenoceptor beta 2 |
|
ISO |
|
RGD |
PMID:17687719 |
RGD:4145098 |
NCBI chr 5:144,259,756...144,398,421
Ensembl chr 5:150,267,554...150,315,892
|
|
G |
CD40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:19470255 |
RGD:5132271 |
NCBI chr20:42,455,711...42,467,139
Ensembl chr20:43,541,619...43,552,994
|
|
G |
CD86 |
CD86 molecule |
|
ISO |
protein:decreased expression:myeloid dendritic cell (mouse) |
RGD |
PMID:20046053 |
RGD:4892291 |
NCBI chr 3:119,151,884...119,217,641
Ensembl chr 3:126,059,008...126,124,339
|
|
G |
CRP |
C-reactive protein |
severity |
ISO |
|
RGD |
PMID:21284715 |
RGD:5131282 |
NCBI chr 1:135,062,102...135,064,402
|
|
G |
CYSLTR1 |
cysteinyl leukotriene receptor 1 |
|
ISO |
associated with Pneumovirus Infections |
RGD |
PMID:16337014 |
RGD:4843953 |
NCBI chr X:67,412,410...67,469,366
Ensembl chr X:77,524,455...77,525,468
|
|
G |
IL17A |
interleukin 17A |
susceptibility |
ISO |
DNA:SNP:promoter:rs2275913 (human) |
RGD |
PMID:20437253 |
RGD:4889139 |
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
|
|
G |
IL1B |
interleukin 1 beta |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:8608647 |
RGD:4143192 |
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:8608647 |
RGD:4143192 |
NCBI chr2A:88,991,646...89,008,013
Ensembl chr2A:114,061,182...114,078,839
|
|
G |
LOC100980531 |
eotaxin |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:17297249 |
RGD:4145460 |
NCBI chr17:22,495,737...22,515,144
Ensembl chr17:22,806,076...22,808,345 Ensembl chr17:22,806,076...22,808,345
|
|
G |
MUC5B |
mucin 5B, oligomeric mucus/gel-forming |
|
ISO |
DNA:polymorphisms:promoter:rs885454,rs17235353, rs7115457 (human) |
RGD |
PMID:15709052 |
RGD:7349353 |
|
|
|
G |
ACE |
angiotensin I converting enzyme |
|
ISO |
|
RGD |
PMID:17097496 |
RGD:4140933 |
NCBI chr17:57,556,294...57,577,294
Ensembl chr17:62,702,341...62,733,853
|
|
G |
ADORA2A |
adenosine A2a receptor |
|
ISO |
|
RGD |
PMID:19766783 |
RGD:4890362 |
NCBI chr22:5,233,876...5,248,622
Ensembl chr22:22,104,253...22,114,189
|
|
G |
CCL17 |
C-C motif chemokine ligand 17 |
|
ISO |
|
RGD |
PMID:18785972 |
RGD:4145604 |
NCBI chr16:37,678,518...37,689,350
Ensembl chr16:56,819,949...56,822,131
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
|
ISO |
|
RGD |
PMID:14611812 |
RGD:2307195 |
NCBI chr17:22,528,154...22,530,091
Ensembl chr17:22,820,890...22,823,384
|
|
G |
CCL22 |
C-C motif chemokine ligand 22 |
|
ISO |
|
RGD |
PMID:20628341 |
RGD:4891471 |
NCBI chr16:37,631,861...37,640,208
Ensembl chr16:56,765,367...56,771,213
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
|
ISO |
mRNA:increased expression:lung (rat) |
RGD |
PMID:14611812 PMID:19840961 |
RGD:2307195 RGD:4889978 |
NCBI chr17:20,915,198...20,923,530
Ensembl chr17:21,210,798...21,219,172
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
mRNA:increased expression:trachea: |
RGD |
PMID:11518728 |
RGD:4145124 |
NCBI chr 3:46,255,725...46,263,285
Ensembl chr 3:47,361,124...47,368,312
|
|
G |
CD86 |
CD86 molecule |
|
ISO |
|
RGD |
PMID:11266944 |
RGD:2307206 |
NCBI chr 3:119,151,884...119,217,641
Ensembl chr 3:126,059,008...126,124,339
|
|
G |
CSF2 |
colony stimulating factor 2 |
|
ISO |
associated with Respiratory Aspiration;protein:increased expression:serum |
RGD |
PMID:18557728 |
RGD:2317286 |
NCBI chr 5:127,496,951...127,499,325
Ensembl chr 5:133,660,775...133,663,146
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:12097412 PMID:16709871 |
RGD:5135441 RGD:5135451 |
NCBI chr 4:48,182,355...48,184,733
Ensembl chr 4:54,020,204...54,022,606
|
|
G |
CXCL11 |
C-X-C motif chemokine ligand 11 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:12097412 |
RGD:5135451 |
NCBI chr 4:48,169,954...48,172,455
Ensembl chr 4:54,007,818...54,010,336
|
|
G |
CXCL9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:12097412 PMID:16709871 |
RGD:5135441 RGD:5135451 |
NCBI chr 4:48,198,478...48,204,658
Ensembl chr 4:54,036,342...54,042,502
|
|
G |
CXCR3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:12097412 PMID:16709871 |
RGD:5135441 RGD:5135451 |
NCBI chr X:60,880,759...60,883,355
Ensembl chr X:70,933,160...70,935,756
|
|
G |
EDN1 |
endothelin 1 |
|
ISO |
human gene in a rat model |
RGD |
PMID:9595474 |
RGD:8662402 |
NCBI chr 6:12,076,312...12,142,861
Ensembl chr 6:12,462,718...12,503,545
|
|
G |
FOXP3 |
forkhead box P3 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:19840961 |
RGD:4889978 |
NCBI chr X:41,550,462...41,567,492
Ensembl chr X:49,402,652...49,417,029
|
|
G |
GZMB |
granzyme B |
|
ISO |
|
RGD |
PMID:19737140 |
RGD:5135518 |
NCBI chr14:5,399,888...5,403,200
Ensembl chr14:23,523,619...23,526,931
|
|
G |
HMOX1 |
heme oxygenase 1 |
|
ISO |
|
RGD |
PMID:12973103 |
RGD:4145412 |
NCBI chr22:16,388,368...16,401,289
Ensembl chr22:34,230,825...34,244,063
|
|
G |
IFNG |
interferon gamma |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16137903 |
|
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
protein:increased expression:bronchoalveolar lavage fluid |
RGD |
PMID:17182591 |
RGD:4146242 |
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
|
|
G |
IL13RA1 |
interleukin 13 receptor subunit alpha 1 |
|
ISO |
|
RGD |
PMID:17182591 |
RGD:4146242 |
NCBI chr X:107,735,233...107,813,282
Ensembl chr X:118,202,285...118,266,770
|
|
G |
IL13RA2 |
interleukin 13 receptor subunit alpha 2 |
|
ISO |
|
RGD |
PMID:17182591 |
RGD:4146242 |
NCBI chr X:104,092,993...104,146,062
Ensembl chr X:114,597,077...114,635,253
|
|
G |
IL17A |
interleukin 17A |
|
ISO |
mRNA:increased expression:trachea |
RGD |
PMID:20393404 |
RGD:4143277 |
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11889437 |
RGD:4143176 |
NCBI chr2A:88,991,646...89,008,013
Ensembl chr2A:114,061,182...114,078,839
|
|
G |
IL4 |
interleukin 4 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:18557728 |
RGD:2317286 |
NCBI chr 5:128,091,342...128,099,886
Ensembl chr 5:134,253,039...134,261,581
|
|
G |
IL6 |
interleukin 6 |
|
ISO |
|
RGD |
PMID:20393404 |
RGD:4143277 |
NCBI chr 7:23,415,922...23,420,767
|
|
G |
MBL2 |
mannose binding lectin 2 |
resistance |
ISO |
DNA:transversion:5' utr:-290C>G rs7096206 (human) |
RGD |
PMID:19104434 |
RGD:4889456 |
NCBI chr10:49,401,364...49,409,328
Ensembl chr10:51,527,758...51,543,432
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression, increased activity:bronchoalveolar lavage fluid |
RGD |
PMID:20417130 |
RGD:5130759 |
NCBI chr20:42,346,305...42,354,018
Ensembl chr20:43,432,389...43,440,129
|
|
G |
MUC1 |
mucin 1, cell surface associated |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:16969297 |
RGD:5131273 |
NCBI chr 1:130,533,508...130,537,866
Ensembl chr 1:134,141,969...134,145,850
|
|
G |
NOD2 |
nucleotide binding oligomerization domain containing 2 |
|
ISO |
|
RGD |
PMID:18158963 |
RGD:5131450 |
NCBI chr16:30,955,976...30,995,451
Ensembl chr16:49,837,891...49,873,773
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
associated with lung transplantation; protein:increased expression:lung |
RGD |
PMID:11112135 |
RGD:4892082 |
NCBI chr17:28,984,295...29,021,516
Ensembl chr17:29,471,510...29,617,093
|
|
G |
NOS3 |
nitric oxide synthase 3 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:15136885 |
RGD:4892068 |
NCBI chr 7:142,577,334...142,600,702
Ensembl chr 7:154,730,009...154,755,233
|
|
G |
SCGB1A1 |
secretoglobin family 1A member 1 |
|
ISO |
associated with lung transplantation; protein:decreased expression:serum,bronchoalveolar lavage |
RGD |
PMID:11981419 |
RGD:5147386 |
NCBI chr11:57,774,560...57,780,334
Ensembl chr11:61,133,649...61,137,873
|
|
G |
SFTPD |
surfactant protein D |
|
ISO |
|
RGD |
PMID:18347569 |
RGD:4143500 |
NCBI chr10:76,275,147...76,318,952
Ensembl chr10:78,965,252...78,974,181
|
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
|
ISO |
DNA:polymorphism (human) |
RGD |
PMID:14593914 |
RGD:4889126 |
NCBI chr15:53,664,968...53,672,277
Ensembl chr15:73,284,566...73,290,636
|
|
G |
EGR1 |
early growth response 1 |
|
ISO |
|
RGD |
PMID:17384085 |
RGD:5132266 |
NCBI chr 5:133,845,305...133,849,291
Ensembl chr 5:139,975,635...139,979,260
|
|
G |
HDAC2 |
histone deacetylase 2 |
treatment |
ISO |
|
RGD |
PMID:22708526 |
RGD:9590258 |
NCBI chr 6:111,731,139...111,761,826
Ensembl chr 6:115,802,367...115,833,004
|
|
G |
IFNG |
interferon gamma |
resistance |
ISO |
|
RGD |
PMID:20953328 |
RGD:4145525 |
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
|
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein:increased secretion:serum (human) |
RGD |
PMID:20350425 |
RGD:4892019 |
NCBI chr17:20,915,198...20,923,530
Ensembl chr17:21,210,798...21,219,172
|
|
G |
CXCR2 |
C-X-C motif chemokine receptor 2 |
disease_progression |
ISO |
associated with Plague |
RGD |
PMID:21356370 |
RGD:5134954 |
NCBI chr2B:105,387,198...105,400,533
Ensembl chr2B:223,997,066...223,998,148
|
|
G |
MBL2 |
mannose binding lectin 2 |
|
ISO |
associated with Down Syndrome; protein:decreased secretion:serum (human) |
RGD |
PMID:19804807 |
RGD:4889483 |
NCBI chr10:49,401,364...49,409,328
Ensembl chr10:51,527,758...51,543,432
|
|
|
G |
CD274 |
CD274 molecule |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:26378990 |
RGD:41412180 |
NCBI chr 9:5,269,270...5,289,629
Ensembl chr 9:5,454,391...5,474,402
|
|
G |
PDCD1 |
programmed cell death 1 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:26378990 |
RGD:41412180 |
NCBI chr12:130,849,353...130,858,776
|
|
G |
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
severity |
ISO |
|
RGD |
PMID:29893841 |
RGD:40890270 |
NCBI chr 1:8,418,570...8,495,435
Ensembl chr 1:9,686,208...9,724,633
|
|
|
G |
CFTR |
CF transmembrane conductance regulator |
susceptibility |
ISO |
associated with pulmonary disease chronic obstructive; DNA:missense mutation:exon:p.R75Q(human) DNA:deletion: :F508del(human) |
RGD |
PMID:10767489 PMID:15463907 |
RGD:4140475 RGD:4140484 |
NCBI chr 7:109,449,847...109,633,023
Ensembl chr 7:122,129,798...122,327,864
|
|
G |
CTLA4 |
cytotoxic T-lymphocyte associated protein 4 |
|
ISO |
DNA:SNPs: :multiple (human) |
RGD |
PMID:19386687 |
RGD:4891509 |
NCBI chr2B:91,054,917...91,106,234
Ensembl chr2B:209,239,417...209,244,498
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
susceptibility |
ISO |
DNA:polymorphism (human) |
RGD |
PMID:15928955 |
RGD:4142512 |
NCBI chr15:53,664,968...53,672,277
Ensembl chr15:73,284,566...73,290,636
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
|
ISO |
DNA:polymorphism (human) |
RGD |
PMID:14593914 |
RGD:4889126 |
Ensembl chr10:134,839,025...134,852,719
|
|
G |
EDN1 |
endothelin 1 |
|
ISO |
Chronic Allergic Airway Inflammation; protein:increased secretion:bronchoalveolar lavage (mouse) |
RGD |
PMID:18631350 |
RGD:4145074 |
NCBI chr 6:12,076,312...12,142,861
Ensembl chr 6:12,462,718...12,503,545
|
|
G |
GC |
GC vitamin D binding protein |
susceptibility |
ISO |
|
RGD |
PMID:12096683 |
RGD:5129516 |
NCBI chr 4:52,431,196...52,473,762
Ensembl chr 4:58,729,236...58,792,073
|
|
G |
GSTM1 |
glutathione S-transferase mu 1 |
severity |
ISO |
DNA:deletion, haplotype: : (human) DNA:deletion: : |
RGD |
PMID:9187680 PMID:15125256 |
RGD:12798508 RGD:4142513 |
Ensembl chr 1:127,979,238...128,010,411
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
ISO |
protein:increased expression:bronchial epithelium (rat) |
RGD |
PMID:19507274 |
RGD:2308951 |
NCBI chr19:9,821,402...9,837,021
Ensembl chr19:10,484,414...10,500,605
|
|
G |
IL10 |
interleukin 10 |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:19507274 |
RGD:2308951 |
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
protein:increased expression:Respiratory Mucosa |
RGD |
PMID:14582911 |
RGD:4759835 |
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
|
|
G |
IL15 |
interleukin 15 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:11742275 |
RGD:4990461 |
NCBI chr 4:133,693,995...134,115,470
Ensembl chr 4:145,402,111...145,416,622
|
|
G |
LOC100980531 |
eotaxin |
|
ISO |
|
RGD |
PMID:11991282 |
RGD:4145442 |
NCBI chr17:22,495,737...22,515,144
Ensembl chr17:22,806,076...22,808,345 Ensembl chr17:22,806,076...22,808,345
|
|
G |
MPO |
myeloperoxidase |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11798689 |
RGD:5130990 |
NCBI chr17:52,333,882...52,357,838
Ensembl chr17:57,201,073...57,212,111
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
|
RGD |
PMID:19938219 |
RGD:4891494 |
NCBI chr17:28,984,295...29,021,516
Ensembl chr17:29,471,510...29,617,093
|
|
G |
NPY |
neuropeptide Y |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9731035 |
|
NCBI chr 7:24,963,056...24,970,803
Ensembl chr 7:24,568,041...24,574,657
|
|
G |
VEGFA |
vascular endothelial growth factor A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19263519 |
|
NCBI chr 6:43,361,053...43,377,366
Ensembl chr 6:44,650,365...44,666,353
|
|
|
G |
EDN1 |
endothelin 1 |
|
ISO |
protein:increased expression:inferior turbinate, nasal gland, inflammatory cell (human) |
RGD |
PMID:8845175 |
RGD:8661738 |
NCBI chr 6:12,076,312...12,142,861
Ensembl chr 6:12,462,718...12,503,545
|
|
|
G |
CD8A |
CD8 subunit alpha |
ameliorates |
ISO |
protein:decreased expression:blood, T cell (human) |
RGD |
PMID:24639246 |
RGD:124715444 |
NCBI chr2A:86,832,559...86,855,772
Ensembl chr2A:88,377,722...88,382,635
|
|
G |
IL17A |
interleukin 17A |
|
ISO |
protein:increased expression:uncinate process, nasal mucosa (human) |
RGD |
PMID:23613503 |
RGD:8696039 |
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
susceptibility |
ISO |
DNA:repeats:intron:IVS2+914_1000dup I/II alleles (human) |
RGD |
PMID:16549749 |
RGD:8549791 |
NCBI chr2A:88,991,646...89,008,013
Ensembl chr2A:114,061,182...114,078,839
|
|
G |
MBL2 |
mannose binding lectin 2 |
|
ISO |
protein:decreased activity:serum: |
RGD |
PMID:23144819 |
RGD:8693716 |
NCBI chr10:49,401,364...49,409,328
Ensembl chr10:51,527,758...51,543,432
|
|
G |
PRG2 |
proteoglycan 2, pro eosinophil major basic protein |
disease_progression |
ISO |
associated with Nasal Polyps; |
RGD |
PMID:24450586 |
RGD:13506943 |
NCBI chr11:52,628,289...52,631,634
Ensembl chr 3:160,118,111...160,122,002
|
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
|
ISO |
protein:increased expression:bronchus |
RGD |
PMID:11865407 |
RGD:4890421 |
NCBI chr10:42,461,398...42,531,576
Ensembl chr10:45,639,946...45,710,016
|
|
G |
ALOX5AP |
arachidonate 5-lipoxygenase activating protein |
|
ISO |
protein:increased expression:bronchus |
RGD |
PMID:11865407 |
RGD:4890421 |
NCBI chr13:12,012,399...12,041,557
Ensembl chr13:30,425,510...30,476,607
|
|
G |
CX3CL1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
|
RGD |
PMID:20696083 |
RGD:4140458 |
NCBI chr16:37,646,447...37,659,078
Ensembl chr16:56,779,065...56,791,760
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:15764644 |
RGD:5135489 |
NCBI chr 4:48,182,355...48,184,733
Ensembl chr 4:54,020,204...54,022,606
|
|
G |
CXCL5 |
C-X-C motif chemokine ligand 5 |
|
ISO |
associated with Asthma |
RGD |
PMID:12751040 |
RGD:5135264 |
NCBI chr 4:50,192,665...50,195,642
Ensembl chr 4:56,024,848...56,027,989
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
treatment |
ISO |
|
RGD |
PMID:28343401 |
RGD:150521550 |
NCBI chr 4:50,452,857...50,456,015
Ensembl chr 4:56,286,708...56,288,083
|
|
G |
CXCR2 |
C-X-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:19864593 |
RGD:5131210 |
NCBI chr2B:105,387,198...105,400,533
Ensembl chr2B:223,997,066...223,998,148
|
|
G |
IL10 |
interleukin 10 |
|
ISO |
|
RGD |
PMID:20696083 |
RGD:4140458 |
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:10358201 |
RGD:4143183 |
NCBI chr2A:89,273,482...89,284,421
Ensembl chr2A:113,784,854...113,795,801
|
|
G |
IL1B |
interleukin 1 beta |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:7734976 |
RGD:7401200 |
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:10358201 PMID:18279051 |
RGD:4143183 RGD:4143207 |
NCBI chr2A:88,991,646...89,008,013
Ensembl chr2A:114,061,182...114,078,839
|
|
G |
IL33 |
interleukin 33 |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:28471975 |
RGD:38596342 |
NCBI chr 9:6,027,014...6,069,540
Ensembl chr 9:6,234,178...6,248,624
|
|
G |
IL4 |
interleukin 4 |
|
ISO |
associated with Asthma;mRNA, protein:increased expression:alveolar macrophage, respiratory system fluid/secretion |
RGD |
PMID:20644177 |
RGD:4140459 |
NCBI chr 5:128,091,342...128,099,886
Ensembl chr 5:134,253,039...134,261,581
|
|
G |
LOC100972354 |
interferon alpha-2 |
treatment |
ISO |
|
RGD |
PMID:6381610 |
RGD:40886344 |
NCBI chr 9:21,245,017...21,246,210
Ensembl chr 9:21,863,062...21,863,736
|
|
G |
LOC100976904 |
growth-regulated alpha protein |
|
ISO |
associated with Pulmonary Disease, Chronic Obstructive;protein:increased expression:respiratory epithelial cell |
RGD |
PMID:20395558 |
RGD:4145446 |
NCBI chr 4:50,325,248...50,327,165
Ensembl chr 4:56,153,899...56,159,474
|
|
G |
PRDX5 |
peroxiredoxin 5 |
|
ISO |
associated with asthma;protein:increased expression:sputum (human) |
RGD |
PMID:18219526 |
RGD:41404684 |
NCBI chr11:59,675,138...59,678,804
Ensembl chr11:63,020,097...63,023,624
|
|
G |
TSLP |
thymic stromal lymphopoietin |
|
ISO |
protein:increased expression:nasal mucus (human) |
RGD |
PMID:28471975 |
RGD:38596342 |
NCBI chr 5:106,440,136...106,446,849
Ensembl chr 5:112,242,490...112,250,130
|
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
|
ISO |
protein:increased expression:lung, macrophage (human) |
RGD |
PMID:21144722 |
RGD:5131112 |
NCBI chr12:6,457,617...6,470,969
Ensembl chr12:6,374,257...6,387,613
|
|
G |
TNFRSF1B |
TNF receptor superfamily member 1B |
|
ISO |
protein:increased expression:lung, lymphocyte (human) |
RGD |
PMID:21144722 |
RGD:5131112 |
NCBI chr 1:10,915,743...10,957,765
Ensembl chr 1:12,130,663...12,172,646
|
|
|
G |
SFTPC |
surfactant protein C |
|
ISO |
OMIM:263000 |
MouseDO |
|
|
NCBI chr 8:21,402,060...21,409,438
Ensembl chr 8:18,345,940...18,348,764
|
|
|
G |
LOC100982859 |
class I histocompatibility antigen, Gogo-B*0101 alpha chain |
susceptibility |
ISO |
DNA:polymorphism:cds:HLA-B*5401 (human) |
RGD |
PMID:9731015 |
RGD:1331522 |
NCBI chr 6:31,106,562...31,109,933
Ensembl chr 6:31,997,381...32,000,067
|
|
G |
MBL2 |
mannose binding lectin 2 |
susceptibility |
ISO |
DNA:SNP:exon:p.G54D(rs1800450)(human) |
RGD |
PMID:15249448 |
RGD:8693755 |
NCBI chr10:49,401,364...49,409,328
Ensembl chr10:51,527,758...51,543,432
|
|
G |
MUC5AC |
mucin 5AC, oligomeric mucus/gel-forming |
|
ISO |
protein:decreased expression:bronchiole epithelium |
RGD |
PMID:15364771 |
RGD:7364741 |
NCBI chr11:1,191,223...1,234,373
|
|
G |
MUC5B |
mucin 5B, oligomeric mucus/gel-forming |
|
ISO |
DNA:insertion/deletion |
RGD |
PMID:15709052 |
RGD:7349353 |
|
|
G |
MUCL3 |
mucin like 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22152429 |
|
NCBI chr 6:30,685,349...30,699,218
|
|
G |
TAP2 |
transporter 2, ATP binding cassette subfamily B member |
susceptibility |
ISO |
DNA:polymorphisms:exon: |
RGD |
PMID:10323341 |
RGD:5147847 |
NCBI chr 6:32,394,586...32,408,297
Ensembl chr 6:33,507,332...33,523,750
|
|
|
G |
C5 |
complement C5 |
|
ISO |
|
RGD |
PMID:2612053 |
RGD:5130160 |
NCBI chr 9:92,069,574...92,202,513
Ensembl chr 9:120,426,354...120,523,856
|
|
G |
GATA2 |
GATA binding protein 2 |
|
ISO |
associated with Pneumocystis Infections |
RGD |
PMID:16774119 |
RGD:9587813 |
NCBI chr 3:125,526,537...125,535,649
Ensembl chr 3:132,890,508...132,899,035
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:16544260 PMID:19752036 |
RGD:4145474 RGD:4145506 |
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
|
|
G |
IL33 |
interleukin 33 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:25746970 |
RGD:39938968 |
NCBI chr 9:6,027,014...6,069,540
Ensembl chr 9:6,234,178...6,248,624
|
|
G |
LOC103783265 |
pulmonary surfactant-associated protein A1 |
susceptibility |
ISO |
|
RGD |
PMID:20413160 |
RGD:4143489 |
NCBI chr10:76,571,312...76,575,820
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:10639453 |
RGD:4891455 |
NCBI chr17:28,984,295...29,021,516
Ensembl chr17:29,471,510...29,617,093
|
|
G |
SFTPD |
surfactant protein D |
susceptibility |
ISO |
|
RGD |
PMID:20413160 |
RGD:4143489 |
NCBI chr10:76,275,147...76,318,952
Ensembl chr10:78,965,252...78,974,181
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:16544260 |
RGD:4145506 |
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
|
|
|
G |
ABO |
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase |
susceptibility |
ISO |
DNA:polymorphism:cds:allele AB (human) |
RGD |
PMID:4375858 PMID:6189297 |
RGD:39938844 RGD:5128836 |
NCBI chr 9:104,354,115...104,399,057
Ensembl chr 9:132,989,574...133,010,324
|
|
G |
APOL6 |
apolipoprotein L6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr22:16,655,209...16,670,813
Ensembl chr22:34,495,750...34,508,922
|
|
G |
ATF3 |
activating transcription factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 1:188,176,728...188,188,842
Ensembl chr 1:193,036,793...193,049,150
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:21408070 |
RGD:5129492 |
NCBI chr19:5,708,211...5,753,178
Ensembl chr19:6,629,287...6,674,699
|
|
G |
CASP1 |
caspase 1 |
|
ISO |
|
RGD |
PMID:19362023 |
RGD:5130181 |
NCBI chr11:99,965,964...99,975,640
Ensembl chr11:103,448,497...103,458,149 Ensembl chr11:103,448,497...103,458,149
|
|
G |
CAT |
catalase |
|
ISO |
|
RGD |
PMID:16804020 PMID:19959187 PMID:20653246 |
RGD:5130201 RGD:5130744 RGD:5130864 |
NCBI chr11:34,413,253...34,446,831
Ensembl chr11:34,289,603...34,323,160
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
|
ISO |
mRNA:increased expression:lung CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:20967263 PMID:23326326 |
RGD:4891425 |
NCBI chr17:22,528,154...22,530,091
Ensembl chr17:22,820,890...22,823,384
|
|
G |
CCL28 |
C-C motif chemokine ligand 28 |
resistance |
ISO |
|
RGD |
PMID:19847203 |
RGD:4892196 |
NCBI chr 5:66,977,643...66,998,420
Ensembl chr 5:72,012,579...72,046,031
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
susceptibility |
ISO |
protein:increased expression:lung (mouse) |
RGD |
PMID:16208318 PMID:20656925 |
RGD:4145452 RGD:4892131 |
NCBI chr17:20,915,198...20,923,530
Ensembl chr17:21,210,798...21,219,172
|
|
G |
CCL8 |
C-C motif chemokine ligand 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr17:22,468,080...22,470,443
Ensembl chr17:22,761,064...22,763,933
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
severity |
ISO |
DNA:frameshift mutation:cds:p.S185_T195del rs333 (human) |
RGD |
PMID:18617426 PMID:19039768 PMID:20875295 |
RGD:4892063 RGD:4892119 RGD:4892122 |
NCBI chr 3:46,273,096...46,278,471
Ensembl chr 3:47,380,321...47,381,379
|
|
G |
CD14 |
CD14 molecule |
|
ISO |
|
RGD |
PMID:17825924 |
RGD:4144809 |
NCBI chr 5:135,996,265...135,997,909
Ensembl chr 5:142,113,082...142,118,966
|
|
G |
CD209 |
CD209 molecule |
susceptibility |
ISO |
|
RGD |
PMID:21191006 |
RGD:5131189 |
NCBI chr19:7,042,033...7,047,350
|
|
G |
CD28 |
CD28 molecule |
|
ISO |
|
RGD |
PMID:21389258 |
RGD:5131611 |
NCBI chr2B:90,938,795...90,971,438
Ensembl chr2B:209,076,388...209,111,213
|
|
G |
CD40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:19922665 |
RGD:5132270 |
NCBI chr20:42,455,711...42,467,139
Ensembl chr20:43,541,619...43,552,994
|
|
G |
CD80 |
CD80 molecule |
|
ISO |
|
RGD |
PMID:10604996 PMID:19922665 |
RGD:5132270 RGD:5132623 |
NCBI chr 3:116,646,590...116,683,725
Ensembl chr 3:123,559,559...123,594,870
|
|
G |
CD86 |
CD86 molecule |
|
ISO |
protein:increased expression:mediastinal lymph node, B cell (mouse) |
RGD |
PMID:19933871 |
RGD:4892570 |
NCBI chr 3:119,151,884...119,217,641
Ensembl chr 3:126,059,008...126,124,339
|
|
G |
CRP |
C-reactive protein |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21509252 |
RGD:5131277 |
NCBI chr 1:135,062,102...135,064,402
|
|
G |
CSF2 |
colony stimulating factor 2 |
|
ISO |
|
RGD |
PMID:20427198 PMID:21474645 |
RGD:5131470 RGD:5131472 |
NCBI chr 5:127,496,951...127,499,325
Ensembl chr 5:133,660,775...133,663,146
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 4:48,182,355...48,184,733
Ensembl chr 4:54,020,204...54,022,606
|
|
G |
DDX60 |
DExD/H-box helicase 60 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 4:160,376,930...160,532,561
|
|
G |
EGR1 |
early growth response 1 |
|
ISO |
mRNA:increased expression:frontal cortex (mouse) |
RGD |
PMID:21289196 |
RGD:5131660 |
NCBI chr 5:133,845,305...133,849,291
Ensembl chr 5:139,975,635...139,979,260
|
|
G |
EIF2AK2 |
eukaryotic translation initiation factor 2 alpha kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr2A:37,130,386...37,184,587
Ensembl chr2A:37,895,814...37,941,686
|
|
G |
FOXP2 |
forkhead box P2 |
|
ISO |
|
RGD |
PMID:18248790 |
RGD:11536002 |
NCBI chr 7:106,040,118...106,648,741
Ensembl chr 7:119,077,332...119,343,893
|
|
G |
GBP1 |
guanylate binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 1:91,763,835...91,776,843
Ensembl chr 1:90,467,260...90,528,491
|
|
G |
HERC5 |
HECT and RLD domain containing E3 ubiquitin protein ligase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 4:80,747,400...80,795,722
Ensembl chr 4:91,470,572...91,518,177
|
|
G |
HERC6 |
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 4:80,669,642...80,733,409
Ensembl chr 4:91,393,415...91,455,756
|
|
G |
IFI27 |
interferon alpha inducible protein 27 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr14:74,742,775...74,748,820
Ensembl chr14:94,046,694...94,082,022
|
|
G |
IFI35 |
interferon induced protein 35 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr17:14,310,106...14,317,648
Ensembl chr17:14,539,625...14,544,931
|
|
G |
IFI44 |
interferon induced protein 44 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 1:77,863,283...77,877,626
Ensembl chr 1:79,943,774...79,958,083
|
|
G |
IFI44L |
interferon induced protein 44 like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 1:77,833,514...77,855,664
Ensembl chr 1:79,914,051...79,936,084
|
|
G |
IFI6 |
interferon alpha inducible protein 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 1:26,929,129...26,935,205
Ensembl chr 1:27,972,866...27,978,890
|
|
G |
IFIH1 |
interferon induced with helicase C domain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr2B:49,560,620...49,612,086
Ensembl chr2B:166,928,994...166,980,170
|
|
G |
IFIT2 |
interferon induced protein with tetratricopeptide repeats 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr10:86,027,170...86,034,246
Ensembl chr10:89,566,827...89,573,795
|
|
G |
IFIT3 |
interferon induced protein with tetratricopeptide repeats 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr10:86,053,139...86,066,193
Ensembl chr10:89,592,578...89,605,800
|
|
G |
IFIT5 |
interferon induced protein with tetratricopeptide repeats 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr10:86,139,816...86,146,244
Ensembl chr10:89,678,703...89,685,839
|
|
G |
IL10 |
interleukin 10 |
susceptibility |
ISO |
|
RGD |
PMID:20200252 |
RGD:4140426 |
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
|
|
G |
IL12B |
interleukin 12B |
|
ISO |
|
RGD |
PMID:16389596 |
RGD:4145426 |
NCBI chr 5:154,706,467...154,722,231
Ensembl chr 5:161,325,303...161,335,381
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:20003352 |
RGD:4888530 |
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
|
|
G |
IL15 |
interleukin 15 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:19234203 PMID:20212069 PMID:21098221 |
RGD:4994196 RGD:4996471 RGD:4996472 |
NCBI chr 4:133,693,995...134,115,470
Ensembl chr 4:145,402,111...145,416,622
|
|
G |
IL15RA |
interleukin 15 receptor subunit alpha |
|
ISO |
|
RGD |
PMID:21098221 |
RGD:4994196 |
NCBI chr10:5,993,583...6,019,967
|
|
G |
IL17A |
interleukin 17A |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:19265125 PMID:19783685 |
RGD:4889102 RGD:4889150 |
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
|
|
G |
IL17RA |
interleukin 17 receptor A |
|
ISO |
|
RGD |
PMID:19783685 |
RGD:4889102 |
NCBI chr22:511,091...541,504
Ensembl chr22:15,950,463...15,974,865
|
|
G |
IL18 |
interleukin 18 |
|
ISO |
|
RGD |
PMID:15606801 |
RGD:4889964 |
NCBI chr11:107,024,376...107,045,194
Ensembl chr11:110,867,586...110,888,371
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11535264 |
RGD:4142860 |
NCBI chr2A:89,273,482...89,284,421
Ensembl chr2A:113,784,854...113,795,801
|
|
G |
IL1B |
interleukin 1 beta |
|
ISO |
|
RGD |
PMID:20438620 |
RGD:4142822 |
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
disease_progression |
ISO |
protein:increased expression:serum |
RGD |
PMID:9439800 PMID:20840779 |
RGD:4143203 RGD:4143228 |
NCBI chr2A:88,991,646...89,008,013
Ensembl chr2A:114,061,182...114,078,839
|
|
G |
IL2 |
interleukin 2 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21603856 |
RGD:5147905 |
NCBI chr 4:114,637,328...114,642,586
Ensembl chr 4:125,782,563...125,787,984
|
|
G |
IL4 |
interleukin 4 |
|
ISO |
|
RGD |
PMID:21092162 |
RGD:5128546 |
NCBI chr 5:128,091,342...128,099,886
Ensembl chr 5:134,253,039...134,261,581
|
|
G |
IL6 |
interleukin 6 |
|
ISO |
|
RGD |
PMID:20731583 |
RGD:4143268 |
NCBI chr 7:23,415,922...23,420,767
|
|
G |
IRF7 |
interferon regulatory factor 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
Ensembl chr11:647,827...651,314
|
|
G |
ISG15 |
ISG15 ubiquitin like modifier |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
Ensembl chr 1:927,418...928,491
|
|
G |
LAMP3 |
lysosomal associated membrane protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 3:180,152,363...180,193,223
Ensembl chr 3:188,324,660...188,363,268
|
|
G |
LOC100974886 |
uncharacterized LOC100974886 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:20967263 PMID:21251691 |
RGD:4891425 RGD:5135026 |
NCBI chr 4:50,092,989...50,095,541
Ensembl chr 4:55,925,562...55,986,555
|
|
G |
LOC100976728 |
interferon-induced protein with tetratricopeptide repeats 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr10:86,117,807...86,129,256
Ensembl chr10:89,667,149...89,668,579
|
|
G |
LOC100976808 |
protein SCO2 homolog, mitochondrial |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr22:30,769,899...30,772,008
Ensembl chr22:49,879,867...49,880,667
|
|
G |
LOC100976904 |
growth-regulated alpha protein |
|
ISO |
protein:increased expression:lung, serum protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:17348295 PMID:20656925 |
RGD:4145366 RGD:4145452 |
NCBI chr 4:50,325,248...50,327,165
Ensembl chr 4:56,153,899...56,159,474
|
|
G |
LOC100995017 |
XIAP-associated factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr17:6,785,040...6,806,177
Ensembl chr17:6,774,951...6,794,947
|
|
G |
LY6E |
lymphocyte antigen 6 family member E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
|
|
G |
LYST |
lysosomal trafficking regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26597256 |
|
NCBI chr 1:211,229,800...211,451,947
Ensembl chr 1:216,231,824...216,436,293
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased activity:lung, heart, brain |
RGD |
PMID:20299740 |
RGD:5130855 |
NCBI chr20:42,346,305...42,354,018
Ensembl chr20:43,432,389...43,440,129
|
|
G |
MX1 |
MX dynamin like GTPase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr21:27,756,768...27,795,307
Ensembl chr21:41,095,928...41,123,019
|
|
G |
MX2 |
MX dynamin like GTPase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr21:27,696,457...27,744,105
Ensembl chr21:41,032,681...41,071,653
|
|
G |
NOS1 |
nitric oxide synthase 1 |
|
ISO |
protein:increased expression:hippocampus |
RGD |
PMID:9552178 |
RGD:5132870 |
NCBI chr12:114,784,232...114,938,385
Ensembl chr12:118,163,655...118,314,005
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
mRNA,protein:increased expression:brain mRNA:increased expression:olfactory epithelium |
RGD |
PMID:17030871 PMID:17674769 PMID:18080188 |
RGD:4891919 RGD:4891937 RGD:4891952 |
NCBI chr17:28,984,295...29,021,516
Ensembl chr17:29,471,510...29,617,093
|
|
G |
OAS1 |
2'-5'-oligoadenylate synthetase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr12:110,511,984...110,525,343
Ensembl chr12:113,896,760...113,921,814
|
|
G |
OAS2 |
2'-5'-oligoadenylate synthetase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
Ensembl chr12:113,968,061...114,001,209
|
|
G |
OAS3 |
2'-5'-oligoadenylate synthetase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr12:110,543,522...110,578,463
Ensembl chr12:113,928,202...113,959,654
|
|
G |
OASL |
2'-5'-oligoadenylate synthetase like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr12:118,602,088...118,621,056
Ensembl chr12:121,971,880...121,990,855
|
|
G |
PARP12 |
poly(ADP-ribose) polymerase family member 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 7:131,962,104...132,001,945
Ensembl chr 7:144,442,973...144,480,006
|
|
G |
PLSCR1 |
phospholipid scramblase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 3:143,528,967...143,558,468
Ensembl chr 3:151,112,483...151,132,964
|
|
G |
PRF1 |
perforin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26597256 |
|
NCBI chr10:67,071,141...67,078,057
Ensembl chr10:69,597,574...69,603,070
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
|
RGD |
PMID:16272346 |
RGD:5143925 |
NCBI chr 1:162,205,534...162,214,130
Ensembl chr 1:166,355,845...166,364,519
|
|
G |
RIGI |
RNA sensor RIG-I |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 9:32,230,012...32,302,159
Ensembl chr 9:33,040,000...33,110,557
|
|
G |
RSAD2 |
radical S-adenosyl methionine domain containing 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr2A:6,873,821...6,906,087
Ensembl chr2A:7,021,937...7,042,961
|
|
G |
RTP4 |
receptor transporter protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 3:184,394,076...184,397,469
Ensembl chr 3:192,857,778...192,864,206
|
|
G |
SERPING1 |
serpin family G member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr11:52,838,502...52,855,781
Ensembl chr11:56,309,686...56,326,639
|
|
G |
SFTPD |
surfactant protein D |
|
ISO |
|
RGD |
PMID:16787926 |
RGD:4143518 |
NCBI chr10:76,275,147...76,318,952
Ensembl chr10:78,965,252...78,974,181
|
|
G |
SIGLEC1 |
sialic acid binding Ig like lectin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr20:3,769,118...3,795,678
Ensembl chr20:3,526,791...3,552,309
|
|
G |
SLC22A8 |
solute carrier family 22 member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23129053 |
|
NCBI chr11:58,345,026...58,368,089
Ensembl chr11:61,696,354...61,719,413
|
|
G |
STAT1 |
signal transducer and activator of transcription 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr2B:78,270,642...78,316,074
Ensembl chr2B:196,186,906...196,232,280
|
|
G |
TDRD7 |
tudor domain containing 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 9:68,502,761...68,586,633
Ensembl chr 9:96,640,789...96,708,145
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
protein:increased expression:monocyte |
RGD |
PMID:18657324 |
RGD:4145339 |
NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331
|
|
G |
TLR3 |
toll like receptor 3 |
|
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:16789835 PMID:18654661 |
RGD:5129136 RGD:5129219 |
NCBI chr 4:178,238,352...178,256,264
Ensembl chr 4:190,446,487...190,462,728
|
|
G |
TMPRSS11D |
transmembrane serine protease 11D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20237084 PMID:23072892 |
|
NCBI chr 4:56,164,300...56,227,415
Ensembl chr 4:62,558,360...62,621,480
|
|
G |
TMPRSS4 |
transmembrane serine protease 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26889029 |
|
NCBI chr11:112,910,223...112,953,677
Ensembl chr11:116,843,287...116,884,767
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21062445 |
RGD:5128683 |
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
|
|
G |
TNFAIP6 |
TNF alpha induced protein 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr2B:38,669,652...38,692,037
Ensembl chr2B:155,933,842...155,956,382
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:17182684 PMID:19497758 |
RGD:5131157 RGD:5131432 |
NCBI chr12:6,457,617...6,470,969
Ensembl chr12:6,374,257...6,387,613
|
|
G |
TNFSF10 |
TNF superfamily member 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 3:169,512,491...169,530,706
Ensembl chr 3:177,694,021...177,712,137
|
|
G |
TOR1B |
torsin family 1 member B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 9:100,930,714...100,938,891
Ensembl chr 9:129,588,325...129,596,287
|
|
G |
TREX1 |
three prime repair exonuclease 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 3:48,387,762...48,389,693
Ensembl chr 3:49,470,222...49,471,331
|
|
G |
TRIM22 |
tripartite motif containing 22 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr11:5,824,176...5,844,990
Ensembl chr11:5,504,864...5,526,730
|
|
G |
UBE2L6 |
ubiquitin conjugating enzyme E2 L6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr11:52,792,573...52,809,253
Ensembl chr11:56,264,907...56,274,733
|
|
G |
UGCG |
UDP-glucose ceramide glucosyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33639165 |
|
NCBI chr 9:83,024,602...83,065,017
Ensembl chr 9:111,184,478...111,222,613
|
|
G |
ZCCHC2 |
zinc finger CCHC-type containing 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr18:55,893,099...55,948,648
Ensembl chr18:59,209,993...59,265,634
|
|
|
G |
CXCL5 |
C-X-C motif chemokine ligand 5 |
|
ISO |
associated with Scleroderma, Diffuse protein:increased expression:serum |
RGD |
PMID:16085216 PMID:18432520 |
RGD:5135258 RGD:5135260 |
NCBI chr 4:50,192,665...50,195,642
Ensembl chr 4:56,024,848...56,027,989
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
ISO |
protein:increased expression:lung, alveolar macrophage (human) |
RGD |
PMID:19218648 |
RGD:4145518 |
NCBI chr19:9,821,402...9,837,021
Ensembl chr19:10,484,414...10,500,605
|
|
G |
IL6 |
interleukin 6 |
|
ISO |
protein:increased expression:bronchoalveolar lavage (rat) |
RGD |
PMID:10988147 |
RGD:11062092 |
NCBI chr 7:23,415,922...23,420,767
|
|
G |
KEAP1 |
kelch like ECH associated protein 1 |
|
ISO |
protein:increased expression:hyperplastic lung epithelium, alveolus (human) |
RGD |
PMID:20718723 |
RGD:6893300 |
NCBI chr19:10,037,544...10,055,091
Ensembl chr19:10,701,303...10,717,604
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
|
ISO |
|
RGD |
PMID:21444868 |
RGD:7245946 |
NCBI chr 1:9,871,700...10,028,704
Ensembl chr 1:11,093,765...11,249,841
|
|
G |
SCGB1A1 |
secretoglobin family 1A member 1 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:15467329 |
RGD:5144148 |
NCBI chr11:57,774,560...57,780,334
Ensembl chr11:61,133,649...61,137,873
|
|
G |
TERT |
telomerase reverse transcriptase |
|
ISO |
ClinVar Annotator: match by term: idiopathic fibrosing alveolitis |
ClinVar |
PMID:9536098 PMID:15814878 PMID:15885610 PMID:16247010 PMID:17460043 PMID:17576681 PMID:18042801 PMID:18460650 PMID:18635888 PMID:18931339 PMID:19561322 PMID:19674077 PMID:19760749 PMID:20301779 PMID:20502709 PMID:21436073 PMID:21483807 PMID:21520174 PMID:21602826 PMID:22853774 PMID:23538340 PMID:23716176 PMID:23901009 PMID:24033266 PMID:24763404 PMID:24833766 PMID:24983628 PMID:25346280 PMID:25365545 PMID:25741868 PMID:25785092 PMID:26024875 PMID:26136524 PMID:26580448 PMID:26859482 PMID:27192671 PMID:27418648 PMID:27540018 PMID:27848944 PMID:28104920 PMID:28492532 PMID:29036293 PMID:29483670 PMID:30426156 PMID:30523342 PMID:30791107 PMID:31268371 PMID:33709208 PMID:33850299 PMID:34019641 PMID:34482403 PMID:34565437 PMID:34890115 PMID:35106810 PMID:35776903 PMID:36622818 PMID:37096215 More...
|
|
Ensembl chr 5:1,300,960...1,338,872
|
|
|
G |
ATM |
ATM serine/threonine kinase |
exacerbates |
ISO |
|
RGD |
PMID:31509427 |
RGD:126779564 |
NCBI chr11:103,109,979...103,256,405
Ensembl chr11:106,584,228...106,727,041
|
|
G |
BTK |
Bruton tyrosine kinase |
ameliorates |
ISO |
Associated with Acute Lung Injury |
RGD |
PMID:29516781 |
RGD:124713566 |
NCBI chr X:90,551,874...90,588,786
Ensembl chr X:100,684,017...100,725,187
|
|
G |
DUOX1 |
dual oxidase 1 |
|
ISO |
protein:decreased expression:blood plasma (human) |
RGD |
PMID:24888898 |
RGD:40903071 |
NCBI chr15:24,077,557...24,113,206
Ensembl chr15:42,431,595...42,467,943
|
|
G |
DUOX2 |
dual oxidase 2 |
severity |
ISO |
|
RGD |
PMID:25751630 PMID:28936773 PMID:29556357 |
RGD:40924644 RGD:40925921 RGD:40925925 |
NCBI chr15:24,040,513...24,061,758
Ensembl chr15:42,395,135...42,414,281
|
|
G |
IFIH1 |
interferon induced with helicase C domain 1 |
|
ISO |
mRNA:increased expression:nasal cavity mucosa (mouse) |
RGD |
PMID:25751630 |
RGD:40925925 |
NCBI chr2B:49,560,620...49,612,086
Ensembl chr2B:166,928,994...166,980,170
|
|
G |
IL21 |
interleukin 21 |
|
ISO |
|
RGD |
PMID:25251568 |
RGD:127285548 |
NCBI chr 4:114,795,979...114,806,936
Ensembl chr 4:125,943,495...125,951,915
|
|
G |
IL27 |
interleukin 27 |
|
ISO |
protein:increased expression:blood serum (human) |
RGD |
PMID:22343630 |
RGD:126790513 |
|
|
G |
IL32 |
interleukin 32 |
|
ISO |
protein:increased expression:blood serum (human) |
RGD |
PMID:18414668 PMID:19291698 PMID:22277801 |
RGD:150340718 RGD:150340729 RGD:150340751 |
NCBI chr16:2,007,018...2,023,757
Ensembl chr16:3,179,637...3,203,929
|
|
G |
MAP3K8 |
mitogen-activated protein kinase kinase kinase 8 |
exacerbates |
ISO |
|
RGD |
PMID:26241898 |
RGD:11055126 |
NCBI chr10:30,579,220...30,607,249
Ensembl chr10:30,933,483...30,960,824
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
ameliorates |
ISO |
|
RGD |
PMID:22514650 |
RGD:150340681 |
NCBI chr10:45,806,748...45,936,362
|
|
G |
MARCO |
macrophage receptor with collagenous structure |
ameliorates |
ISO |
|
RGD |
PMID:21562316 |
RGD:41412197 |
NCBI chr2B:5,896,433...5,940,284
Ensembl chr2B:119,475,677...119,520,385
|
|
G |
MAVS |
mitochondrial antiviral signaling protein |
disease_progression |
ISO |
|
RGD |
PMID:27438481 |
RGD:40903047 |
NCBI chr20:3,885,044...3,903,554
Ensembl chr20:3,659,559...3,701,089
|
|
G |
MX1 |
MX dynamin like GTPase 1 |
ameliorates |
ISO |
human gene in a mouse model |
RGD |
PMID:30945621 PMID:31653718 |
RGD:126777673 RGD:126777680 |
NCBI chr21:27,756,768...27,795,307
Ensembl chr21:41,095,928...41,123,019
|
|
G |
PLAC8 |
placenta associated 8 |
|
ISO |
|
RGD |
PMID:32639988 |
RGD:40925929 |
NCBI chr 4:41,089,847...41,115,061
Ensembl chr 4:46,943,940...46,964,131
|
|
G |
PPIA |
peptidylprolyl isomerase A |
ameliorates |
ISO |
human gene in a mouse model |
RGD |
PMID:27354005 |
RGD:150429624 |
NCBI chr 7:45,510,450...45,515,448
Ensembl chr 7:45,578,765...45,605,545
|
|
G |
RIGI |
RNA sensor RIG-I |
|
ISO |
mRNA:increased expression:nasal cavity mucosa (mouse) |
RGD |
PMID:25751630 |
RGD:40925925 |
NCBI chr 9:32,230,012...32,302,159
Ensembl chr 9:33,040,000...33,110,557
|
|
G |
RIPK3 |
receptor interacting serine/threonine kinase 3 |
exacerbates susceptibility |
ISO |
|
RGD |
PMID:27321907 PMID:28410401 PMID:32200799 |
RGD:127229911 RGD:127229918 RGD:127229922 |
NCBI chr14:5,112,512...5,116,486
Ensembl chr14:23,235,796...23,239,821
|
|
G |
SAA1 |
serum amyloid A1 |
|
ISO |
protein:increased expression:blood plasma (human) |
RGD |
PMID:24888898 |
RGD:40903071 |
NCBI chr11:18,301,367...18,305,137
Ensembl chr11:17,986,725...17,990,414
|
|
G |
STAT2 |
signal transducer and activator of transcription 2 |
exacerbates |
ISO |
|
RGD |
PMID:30337919 |
RGD:41789626 |
NCBI chr12:32,555,523...32,574,137
Ensembl chr12:32,808,586...32,827,732
|
|
|
G |
AGER |
advanced glycosylation end-product specific receptor |
|
ISO |
|
RGD |
PMID:21423669 |
RGD:5508765 |
NCBI chr 6:31,828,363...31,831,981
Ensembl chr 6:32,708,251...32,711,641
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
severity |
ISO |
|
RGD |
PMID:11160230 |
RGD:11528533 |
NCBI chr17:22,528,154...22,530,091
Ensembl chr17:22,820,890...22,823,384
|
|
G |
CCL20 |
C-C motif chemokine ligand 20 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:20926800 |
RGD:7483599 |
NCBI chr2B:115,052,768...115,056,479
Ensembl chr2B:233,862,505...233,866,225
|
|
G |
CCR6 |
C-C motif chemokine receptor 6 |
disease_progression |
ISO |
|
RGD |
PMID:17379855 |
RGD:7483617 |
NCBI chr 6:165,094,563...165,109,774
Ensembl chr 6:170,069,689...170,084,779
|
|
G |
CXCR3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:17298426 |
RGD:5135501 |
NCBI chr X:60,880,759...60,883,355
Ensembl chr X:70,933,160...70,935,756
|
|
G |
CYP2C19 |
cytochrome P450 family 2 subfamily C member 19 |
treatment |
ISO |
DNA:polymorphisms:cds: |
RGD |
PMID:26861072 |
RGD:124713410 |
NCBI chr10:91,375,255...91,465,215
Ensembl chr10:94,884,472...94,970,065
|
|
G |
ELANE |
elastase, neutrophil expressed |
|
ISO |
|
RGD |
PMID:24054721 |
RGD:10450528 |
NCBI chr19:276,499...280,598
|
|
G |
IL17A |
interleukin 17A |
severity |
ISO |
|
RGD |
PMID:21807912 |
RGD:8698654 |
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
|
|
G |
LOC100982531 |
cytochrome b-245 heavy chain |
|
ISO |
|
RGD |
PMID:24054721 |
RGD:10450528 |
NCBI chr X:30,230,394...30,267,379
Ensembl chr X:37,939,704...37,973,183
|
|
G |
MBL2 |
mannose binding lectin 2 |
|
ISO |
DNA:SNP:exon:rs5030737(human) |
RGD |
PMID:17311505 |
RGD:8693758 |
NCBI chr10:49,401,364...49,409,328
Ensembl chr10:51,527,758...51,543,432
|
|
G |
PTX3 |
pentraxin 3 |
severity |
ISO |
protein:increased expression:bronchoalveolar lavage fluid (human) DNA:SNPs, missense mutation:intron, cds:rs2305619, rs1840680, rs3816527 |
RGD |
PMID:28487045 PMID:30275011 |
RGD:38501097 RGD:38508892 |
NCBI chr 3:154,485,470...154,492,293
Ensembl chr 3:162,537,577...162,543,652
|
|
G |
S100B |
S100 calcium binding protein B |
|
ISO |
|
RGD |
PMID:21423669 |
RGD:5508765 |
NCBI chr21:33,063,845...33,070,073
Ensembl chr21:46,197,750...46,203,953
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
|
RGD |
PMID:16113258 |
RGD:8553022 |
NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331
|
|
G |
TLR4 |
toll like receptor 4 |
susceptibility |
ISO |
DNA:polymorphism:exon:p.D299G(human) |
RGD |
PMID:18275280 |
RGD:5130863 |
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
|
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
treatment |
ISO |
|
RGD |
PMID:12917249 |
RGD:11528529 |
NCBI chr17:22,528,154...22,530,091
Ensembl chr17:22,820,890...22,823,384
|
|
G |
CD209 |
CD209 molecule |
susceptibility |
ISO |
DNA:SNPs:3'utr,intron:multiple |
RGD |
PMID:22384201 |
RGD:39938996 |
NCBI chr19:7,042,033...7,047,350
|
|
G |
FGF2 |
fibroblast growth factor 2 |
treatment |
ISO |
|
RGD |
PMID:23303813 |
RGD:8655596 |
NCBI chr 4:115,005,136...115,076,369
Ensembl chr 4:126,149,813...126,214,942
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
DNA:polymorphism, haplotype:promoter:-889C>T (human) |
RGD |
PMID:18484169 |
RGD:4142867 |
NCBI chr2A:89,273,482...89,284,421
Ensembl chr2A:113,784,854...113,795,801
|
|
G |
IL1B |
interleukin 1 beta |
|
ISO |
DNA:polymorphism, haplotype: :-511C>T (human) |
RGD |
PMID:18484169 |
RGD:4142867 |
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
|
|
G |
ITIH4 |
inter-alpha-trypsin inhibitor heavy chain 4 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion, serum |
RGD |
PMID:24360996 |
RGD:40903005 |
NCBI chr 3:52,754,664...52,774,867
Ensembl chr 3:53,980,668...53,998,038
|
|
G |
MBL2 |
mannose binding lectin 2 |
treatment |
ISO |
|
RGD |
PMID:17335555 |
RGD:8693746 |
NCBI chr10:49,401,364...49,409,328
Ensembl chr10:51,527,758...51,543,432
|
|
G |
PTX3 |
pentraxin 3 |
no_association susceptibility |
ISO |
DNA:SNP, missense mutation:intron, cds:rs2305619, rs3816527 protein:increased expression:plasma DNA:SNP:intron:rs1840680 (human) protein:increased expression:bronchoalveolar lavage fluid, plasma (human) |
RGD |
PMID:29020397 PMID:29964232 |
RGD:38501098 RGD:38508894 |
NCBI chr 3:154,485,470...154,492,293
Ensembl chr 3:162,537,577...162,543,652
|
|
G |
VEGFA |
vascular endothelial growth factor A |
treatment |
ISO |
|
RGD |
PMID:23303813 |
RGD:8655596 |
NCBI chr 6:43,361,053...43,377,366
Ensembl chr 6:44,650,365...44,666,353
|
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
|
ISO |
|
RGD |
PMID:11207292 |
RGD:38549344 |
NCBI chr 4:50,452,857...50,456,015
Ensembl chr 4:56,286,708...56,288,083
|
|
G |
IL23A |
interleukin 23 subunit alpha |
severity |
ISO |
|
RGD |
PMID:16157683 |
RGD:39457940 |
NCBI chr12:32,575,321...32,576,856
Ensembl chr12:32,828,902...32,830,617
|
|
G |
IRAK3 |
interleukin 1 receptor associated kinase 3 |
severity |
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:20864681 PMID:22729155 |
RGD:35316077 RGD:36049798 |
NCBI chr12:22,661,613...22,721,203
Ensembl chr12:23,168,346...23,227,148
|
|
G |
LCN2 |
lipocalin 2 |
ameliorates exacerbates |
ISO |
protein:increased expression:serum protein:increased expression:lung |
RGD |
PMID:19342674 PMID:25234944 PMID:29633303 |
RGD:126725082 RGD:126725084 RGD:126725085 |
NCBI chr 9:99,259,278...99,274,494
Ensembl chr 9:127,940,799...127,944,798
|
|
G |
PLAC8 |
placenta associated 8 |
severity |
ISO |
|
RGD |
PMID:17404296 |
RGD:40924563 |
NCBI chr 4:41,089,847...41,115,061
Ensembl chr 4:46,943,940...46,964,131
|
|
G |
TREM1 |
triggering receptor expressed on myeloid cells 1 |
disease_progression |
ISO |
|
RGD |
PMID:24396044 |
RGD:126925976 |
NCBI chr 6:40,861,283...40,874,446
Ensembl chr 6:42,163,337...42,183,091
|
|
|
G |
ADA |
adenosine deaminase |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:9255891 |
RGD:5128857 |
NCBI chr20:40,950,238...40,982,481
Ensembl chr20:42,044,613...42,076,868
|
|
G |
CX3CL1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
|
RGD |
PMID:16113250 |
RGD:4891897 |
NCBI chr16:37,646,447...37,659,078
Ensembl chr16:56,779,065...56,791,760
|
|
G |
CXCL6 |
C-X-C motif chemokine ligand 6 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:11254553 |
RGD:5135252 |
NCBI chr 4:50,357,643...50,359,822
Ensembl chr 4:56,189,961...56,192,402
|
|
G |
CXCR2 |
C-X-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:11254553 |
RGD:5135252 |
NCBI chr2B:105,387,198...105,400,533
Ensembl chr2B:223,997,066...223,998,148
|
|
G |
IFNG |
interferon gamma |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11349020 |
|
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
|
|
G |
IL18 |
interleukin 18 |
|
ISO |
|
RGD |
PMID:11083766 |
RGD:4889865 |
NCBI chr11:107,024,376...107,045,194
Ensembl chr11:110,867,586...110,888,371
|
|
G |
LOC100974886 |
uncharacterized LOC100974886 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:11254553 |
RGD:5135252 |
NCBI chr 4:50,092,989...50,095,541
Ensembl chr 4:55,925,562...55,986,555
|
|
G |
LOC100976904 |
growth-regulated alpha protein |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:11254553 |
RGD:5135252 |
NCBI chr 4:50,325,248...50,327,165
Ensembl chr 4:56,153,899...56,159,474
|
|
G |
MBL2 |
mannose binding lectin 2 |
susceptibility |
ISO |
|
RGD |
PMID:19073229 |
RGD:12910934 |
NCBI chr10:49,401,364...49,409,328
Ensembl chr10:51,527,758...51,543,432
|
|
G |
NOD1 |
nucleotide binding oligomerization domain containing 1 |
|
ISO |
|
RGD |
PMID:20685341 |
RGD:5131443 |
NCBI chr 7:31,060,245...31,109,012
Ensembl chr 7:31,182,275...31,208,742
|
|
G |
NOD2 |
nucleotide binding oligomerization domain containing 2 |
|
ISO |
|
RGD |
PMID:20685341 |
RGD:5131443 |
NCBI chr16:30,955,976...30,995,451
Ensembl chr16:49,837,891...49,873,773
|
|
G |
TLR5 |
toll like receptor 5 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Legionnaire disease, susceptibility to |
ClinVar OMIM |
PMID:14623910 PMID:16027372 PMID:23447684 |
|
NCBI chr 1:198,787,046...198,819,537
Ensembl chr 1:203,798,767...203,801,343
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
|
ISO |
|
RGD |
PMID:18838275 |
RGD:5131445 |
NCBI chr12:6,457,617...6,470,969
Ensembl chr12:6,374,257...6,387,613
|
|
G |
TNFRSF1B |
TNF receptor superfamily member 1B |
|
ISO |
|
RGD |
PMID:18838275 |
RGD:5131445 |
NCBI chr 1:10,915,743...10,957,765
Ensembl chr 1:12,130,663...12,172,646
|
|
|
G |
ADA |
adenosine deaminase |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:9255891 |
RGD:5128857 |
NCBI chr20:40,950,238...40,982,481
Ensembl chr20:42,044,613...42,076,868
|
|
G |
ATP1B2 |
ATPase Na+/K+ transporting subunit beta 2 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr17:7,681,831...7,688,710
Ensembl chr17:7,669,626...7,673,834
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein:increased secretion:lung, secretion (mouse) |
RGD |
PMID:18717637 |
RGD:4891914 |
NCBI chr17:20,915,198...20,923,530
Ensembl chr17:21,210,798...21,219,172
|
|
G |
CCL8 |
C-C motif chemokine ligand 8 |
|
ISO |
|
RGD |
PMID:16988274 |
RGD:4892091 |
NCBI chr17:22,468,080...22,470,443
Ensembl chr17:22,761,064...22,763,933
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
|
ISO |
protein:increased expression:lung, T-helper cell (mouse) |
RGD |
PMID:16988274 |
RGD:4892091 |
NCBI chr 3:46,273,096...46,278,471
Ensembl chr 3:47,380,321...47,381,379
|
|
G |
CLEC5A |
C-type lectin domain containing 5A |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 7:133,851,242...133,870,793
Ensembl chr 7:146,320,331...146,339,905
|
|
G |
COL3A1 |
collagen type III alpha 1 chain |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr2B:76,285,115...76,322,703
Ensembl chr2B:194,204,613...194,242,956
|
|
G |
COL6A1 |
collagen type VI alpha 1 chain |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr21:32,322,185...32,346,850
Ensembl chr21:45,584,096...45,607,240
|
|
G |
COL6A2 |
collagen type VI alpha 2 chain |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr21:32,442,859...32,478,076
Ensembl chr21:45,710,491...45,730,895
|
|
G |
CRP |
C-reactive protein |
|
ISO |
|
RGD |
PMID:21426633 |
RGD:5131292 |
NCBI chr 1:135,062,102...135,064,402
|
|
G |
DNASE1L3 |
deoxyribonuclease 1L3 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 3:58,127,491...58,146,177
Ensembl chr 3:59,542,243...59,560,363
|
|
G |
FCER2 |
Fc epsilon receptor II |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr19:6,978,116...6,989,986
Ensembl chr19:7,834,106...7,844,924
|
|
G |
FLT1 |
fms related receptor tyrosine kinase 1 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr13:9,584,850...9,779,542
|
|
G |
GALC |
galactosylceramidase |
|
ISO |
protein:increased expression:serum (mouse) associated with Guillain-Barre syndrome; protein:increased expression:Cerebrospinal fluid, serum (human) protein:increased expression:serum (human) associated with Guillain-Barre syndrome; protein:increased expression:serum (human) |
RGD |
PMID:12225900 PMID:27490360 PMID:29301655 PMID:30396892 |
RGD:38599168 RGD:38599169 RGD:38599171 RGD:38599172 |
NCBI chr14:68,545,070...68,605,730
Ensembl chr14:87,905,098...87,965,770
|
|
G |
HDC |
histidine decarboxylase |
|
ISO |
|
RGD |
PMID:17158962 |
RGD:5143920 |
NCBI chr15:29,188,296...29,212,327
Ensembl chr15:47,510,629...47,534,577
|
|
G |
HTRA3 |
HtrA serine peptidase 3 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
Ensembl chr 4:8,335,529...8,374,510
|
|
G |
IFNG |
interferon gamma |
|
ISO |
mRNA:increased expression:lung: |
RGD |
PMID:7935058 |
RGD:10755754 |
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:20416219 |
RGD:4145765 |
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
|
|
G |
IL22RA2 |
interleukin 22 receptor subunit alpha 2 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 6:134,904,634...134,934,328
Ensembl chr 6:138,992,202...139,021,843
|
|
G |
INHBA |
inhibin subunit beta A |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 7:42,538,591...42,556,578
Ensembl chr 7:42,580,730...42,595,097
|
|
G |
KLRF1 |
killer cell lectin like receptor F1 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr12:9,875,505...9,893,012
Ensembl chr12:10,124,779...10,142,237
|
|
G |
MS4A1 |
membrane spanning 4-domains A1 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr11:55,691,750...55,706,697
Ensembl chr11:59,134,617...59,149,521
|
|
G |
PLD4 |
phospholipase D family member 4 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr14:85,574,724...85,587,176
Ensembl chr14:105,360,584...105,369,247
|
|
G |
SPIB |
Spi-B transcription factor |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr19:47,382,653...47,395,178
Ensembl chr19:56,251,356...56,297,611
|
|
G |
TCF7 |
transcription factor 7 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 5:129,518,134...129,549,972
Ensembl chr 5:135,671,095...135,702,734
|
|
G |
TCL1A |
TCL1 family AKT coactivator A |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr14:76,339,614...76,343,546
Ensembl chr14:95,664,120...95,667,375
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:20416219 |
RGD:4145765 |
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
|
|
G |
TNFRSF13C |
TNF receptor superfamily member 13C |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr22:22,816,504...22,819,584
|
|
|
G |
PTCH1 |
patched 1 |
|
ISO |
mRNA:decreased expression:epithelium of nasopharynx |
RGD |
PMID:23001130 |
RGD:150523839 |
NCBI chr 9:66,542,675...66,616,820
Ensembl chr 9:94,668,365...94,741,453
|
|
|
G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
|
ISO |
protein:decreased expression:serum |
RGD |
PMID:19725899 |
RGD:5686851 |
NCBI chr 3:183,876,051...183,889,723
Ensembl chr 3:192,341,320...192,354,885
|
|
G |
ALB |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19389874 |
|
NCBI chr 4:50,773,244...50,790,474
Ensembl chr 4:56,605,322...56,622,418
|
|
G |
ALOX5AP |
arachidonate 5-lipoxygenase activating protein |
|
ISO |
protein:increased expression:nasal turbinate |
RGD |
PMID:19364335 |
RGD:5147461 |
NCBI chr13:12,012,399...12,041,557
Ensembl chr13:30,425,510...30,476,607
|
|
G |
CAT |
catalase |
|
ISO |
protein:decreased expression:plasma |
RGD |
PMID:20493834 |
RGD:5130771 |
NCBI chr11:34,413,253...34,446,831
Ensembl chr11:34,289,603...34,323,160
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
|
ISO |
protein:increased expression:nasal turbinate, mucosa (human) |
RGD |
PMID:9865755 |
RGD:8548839 |
NCBI chr17:22,528,154...22,530,091
Ensembl chr17:22,820,890...22,823,384
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
mRNA:increased expression:Nasal Mucosa |
RGD |
PMID:17982926 |
RGD:4145109 |
NCBI chr 3:46,255,725...46,263,285
Ensembl chr 3:47,361,124...47,368,312
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
|
ISO |
mRNA:increased expression:nasal mucosa (human) |
RGD |
PMID:17982926 |
RGD:4145109 |
NCBI chr 3:46,273,096...46,278,471
Ensembl chr 3:47,380,321...47,381,379
|
|
G |
CD40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:20226305 |
RGD:5132269 |
NCBI chr20:42,455,711...42,467,139
Ensembl chr20:43,541,619...43,552,994
|
|
G |
CD86 |
CD86 molecule |
|
ISO |
protein:increased expression:nasal mucosa, dendritic cell (human) |
RGD |
PMID:17088138 |
RGD:4892343 |
NCBI chr 3:119,151,884...119,217,641
Ensembl chr 3:126,059,008...126,124,339
|
|
G |
CHIA |
chitinase acidic |
|
ISO |
mRNA, protein:increased expression:turbinate, mucosa (human) |
RGD |
PMID:20422678 |
RGD:5037226 |
NCBI chr 1:113,935,888...113,965,541
Ensembl chr 1:126,381,724...126,391,909
|
|
G |
EGR1 |
early growth response 1 |
|
ISO |
DNA:snp:5' utr:g.-4071A>G rs7729723 (human) |
RGD |
PMID:19833116 |
RGD:5131984 |
NCBI chr 5:133,845,305...133,849,291
Ensembl chr 5:139,975,635...139,979,260
|
|
G |
F2RL1 |
F2R like trypsin receptor 1 |
|
ISO |
|
RGD |
PMID:17727088 |
RGD:4892590 |
Ensembl chr 5:39,006,331...39,024,265
|
|
G |
GSTP1 |
glutathione S-transferase pi 1 |
susceptibility |
ISO |
DNA:polymorphism:exon:p.I105V (rs1695) (human) |
RGD |
PMID:17181111 |
RGD:4142523 |
NCBI chr11:62,942,756...62,945,701
Ensembl chr11:66,253,421...66,256,472
|
|
G |
HMOX1 |
heme oxygenase 1 |
|
ISO |
mRNA, protein:increased expression: nasal mucosa |
RGD |
PMID:16540907 |
RGD:4145406 |
NCBI chr22:16,388,368...16,401,289
Ensembl chr22:34,230,825...34,244,063
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
ISO |
protein:increased secretion:nasopharynx (human) protein:increased expression:lung, endothelium (mouse) |
RGD |
PMID:19047814 PMID:19968652 |
RGD:4145464 RGD:4145520 |
NCBI chr19:9,821,402...9,837,021
Ensembl chr19:10,484,414...10,500,605
|
|
G |
IFNGR1 |
interferon gamma receptor 1 |
|
ISO |
DNA: SNP: Leu467Pro |
RGD |
PMID:12851715 |
RGD:6480431 |
NCBI chr 6:134,958,270...134,980,560
Ensembl chr 6:139,045,821...139,068,053
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
mRNA, protein:increased expression:nasal mucosa |
RGD |
PMID:8520776 |
RGD:4782826 |
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
|
|
G |
IL17A |
interleukin 17A |
severity |
ISO |
protein:increased expression:serum |
RGD |
PMID:19226302 |
RGD:4889151 |
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
|
|
G |
IL18 |
interleukin 18 |
susceptibility |
ISO |
DNA:SNP:promoter:c. -607A>C (rs1946518) (human) |
RGD |
PMID:16406079 |
RGD:4889924 |
NCBI chr11:107,024,376...107,045,194
Ensembl chr11:110,867,586...110,888,371
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
DNA:polymorphism:exon:c.4845G>T (human) |
RGD |
PMID:14533660 |
RGD:4142859 |
NCBI chr2A:89,273,482...89,284,421
Ensembl chr2A:113,784,854...113,795,801
|
|
G |
IL1R1 |
interleukin 1 receptor type 1 |
|
ISO |
|
RGD |
PMID:18637763 |
RGD:5037238 |
Ensembl chr2A:103,193,131...103,230,005
|
|
G |
IL2 |
interleukin 2 |
|
ISO |
protein:decreased expression:serum: |
RGD |
PMID:17608155 |
RGD:8662959 |
NCBI chr 4:114,637,328...114,642,586
Ensembl chr 4:125,782,563...125,787,984
|
|
G |
IL4 |
interleukin 4 |
treatment |
ISO |
protein:increased expression:serum |
RGD |
PMID:9237816 PMID:15329007 PMID:21171297 |
RGD:5128559 RGD:7829804 RGD:7829817 |
NCBI chr 5:128,091,342...128,099,886
Ensembl chr 5:134,253,039...134,261,581
|
|
G |
IL5 |
interleukin 5 |
|
ISO |
protein: increased levels: sputum |
RGD |
PMID:22186238 |
RGD:5687140 |
NCBI chr 5:127,955,377...127,961,726
Ensembl chr 5:134,119,608...134,121,675
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
|
ISO |
protein:increased expression:nasal mucosa: |
RGD |
PMID:19786210 |
RGD:5130872 |
NCBI chr16:35,711,866...35,738,881
Ensembl chr16:54,812,694...54,844,279
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:nasal mucosa: |
RGD |
PMID:19786210 |
RGD:5130872 |
NCBI chr20:42,346,305...42,354,018
Ensembl chr20:43,432,389...43,440,129
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased expression:nasal mucosa |
RGD |
PMID:14587983 |
RGD:4892078 |
NCBI chr17:28,984,295...29,021,516
Ensembl chr17:29,471,510...29,617,093
|
|
G |
NOS3 |
nitric oxide synthase 3 |
|
ISO |
DNA:snp:promoter:g.-786T>C (human) |
RGD |
PMID:18086269 |
RGD:4892054 |
NCBI chr 7:142,577,334...142,600,702
Ensembl chr 7:154,730,009...154,755,233
|
|
G |
NR3C1 |
nuclear receptor subfamily 3 group C member 1 |
|
ISO |
protein:altered expression:nasal mucosa |
RGD |
PMID:20185258 |
RGD:4892593 |
NCBI chr 5:138,634,278...139,089,171
Ensembl chr 5:144,741,452...144,865,269
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
|
ISO |
mRNA, protein:increased expression:nasal mucosa (human) |
RGD |
PMID:17116814 |
RGD:8552811 |
NCBI chr 3:12,215,322...12,361,669
Ensembl chr 3:12,622,397...12,705,060
|
|
G |
PTGS1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO |
protein:increased expression:respiratory system epithelium |
RGD |
PMID:19364335 |
RGD:5147461 |
NCBI chr 9:93,495,365...93,517,557
Ensembl chr 9:121,837,095...121,859,283
|
|
G |
TBXA2R |
thromboxane A2 receptor |
treatment |
ISO |
|
RGD |
PMID:15247523 |
RGD:11059532 |
NCBI chr19:2,621,606...2,632,800
Ensembl chr19:3,570,290...3,581,924
|
|
|
G |
PLAU |
plasminogen activator, urokinase |
|
ISO |
Gene product used in treatment of disease |
RGD |
PMID:20304453 |
RGD:4891955 |
NCBI chr10:70,433,340...70,441,569
Ensembl chr10:73,105,895...73,113,136
|
|
G |
TNC |
tenascin C |
|
ISO |
protein:increased expression:pleura |
RGD |
PMID:10950882 |
RGD:4889594 |
NCBI chr 9:86,125,672...86,222,804
Ensembl chr 9:114,486,778...114,584,299
|
|
G |
TREM1 |
triggering receptor expressed on myeloid cells 1 |
treatment |
ISO |
|
RGD |
PMID:20819512 |
RGD:127284851 |
NCBI chr 6:40,861,283...40,874,446
Ensembl chr 6:42,163,337...42,183,091
|
|
|
G |
ADA |
adenosine deaminase |
|
ISO |
protein:increased activity:pleural fluid: protein:increased activity:serum: protein:increased expression:serum: |
RGD |
PMID:1689629 PMID:1818842 PMID:18357489 PMID:21860532 |
RGD:152995280 RGD:152995288 RGD:152995292 RGD:152998934 |
NCBI chr20:40,950,238...40,982,481
Ensembl chr20:42,044,613...42,076,868
|
|
G |
ADA2 |
adenosine deaminase 2 |
treatment |
ISO |
|
RGD |
PMID:8656037 |
RGD:152995258 |
NCBI chr22:606,220...648,902
Ensembl chr22:16,042,295...16,081,949
|
|
G |
CCL22 |
C-C motif chemokine ligand 22 |
|
ISO |
|
RGD |
PMID:20337996 |
RGD:4891473 |
NCBI chr16:37,631,861...37,640,208
Ensembl chr16:56,765,367...56,771,213
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:19159432 |
RGD:4145106 |
NCBI chr 3:46,255,725...46,263,285
Ensembl chr 3:47,361,124...47,368,312
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
|
ISO |
protein:increased expression:pleural fluid, natural killer cell (human) |
RGD |
PMID:19159432 |
RGD:4145106 |
NCBI chr 3:46,273,096...46,278,471
Ensembl chr 3:47,380,321...47,381,379
|
|
G |
FOXP3 |
forkhead box P3 |
disease_progression |
ISO |
associated with human immunodeficiency virus infectious disease; |
RGD |
PMID:21303360 |
RGD:36947878 |
NCBI chr X:41,550,462...41,567,492
Ensembl chr X:49,402,652...49,417,029
|
|
G |
IL1B |
interleukin 1 beta |
|
ISO |
DNA:polymorphism: :3953T>C (human) |
RGD |
PMID:10377182 |
RGD:4143226 |
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
DNA:repeat (human) |
RGD |
PMID:10377182 |
RGD:4143226 |
NCBI chr2A:88,991,646...89,008,013
Ensembl chr2A:114,061,182...114,078,839
|
|
G |
IL27 |
interleukin 27 |
exacerbates |
ISO |
associated with Pleural Effusion;protein:increased expression:pleural fluid (human) protein:increased expression:alveolar system (human) |
RGD |
PMID:23962500 PMID:25753767 PMID:28844060 PMID:31819557 |
RGD:126790505 RGD:126790517 RGD:126790523 RGD:126790549 |
|
|
G |
IL33 |
interleukin 33 |
|
ISO |
protein:increased expression:pleural fluid: |
RGD |
PMID:23301222 |
RGD:39939042 |
NCBI chr 9:6,027,014...6,069,540
Ensembl chr 9:6,234,178...6,248,624
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:pleura: |
RGD |
PMID:18715875 |
RGD:5129700 |
NCBI chr20:42,346,305...42,354,018
Ensembl chr20:43,432,389...43,440,129
|
|
G |
TLR4 |
toll like receptor 4 |
|
ISO |
|
RGD |
PMID:18295348 |
RGD:4144193 |
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
|
|
G |
TNC |
tenascin C |
|
ISO |
protein:increased expression:pleura |
RGD |
PMID:10950882 |
RGD:4889594 |
NCBI chr 9:86,125,672...86,222,804
Ensembl chr 9:114,486,778...114,584,299
|
|
|
G |
ADA |
adenosine deaminase |
|
ISO |
|
RGD |
PMID:16860713 |
RGD:5128847 |
NCBI chr20:40,950,238...40,982,481
Ensembl chr20:42,044,613...42,076,868
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
|
ISO |
|
RGD |
PMID:9109363 |
RGD:4890429 |
NCBI chr10:42,461,398...42,531,576
Ensembl chr10:45,639,946...45,710,016
|
|
G |
ANXA1 |
annexin A1 |
|
ISO |
|
RGD |
PMID:15784654 |
RGD:2306907 |
NCBI chr 9:51,647,404...51,665,990
Ensembl chr 9:71,929,728...71,948,779
|
|
G |
BDKRB1 |
bradykinin receptor B1 |
|
ISO |
|
RGD |
PMID:11853231 |
RGD:5129218 |
NCBI chr14:76,885,923...76,894,456
|
|
G |
BDKRB2 |
bradykinin receptor B2 |
|
ISO |
|
RGD |
PMID:9208140 PMID:15316088 |
RGD:4891029 RGD:4891041 |
NCBI chr14:76,832,833...76,873,860
Ensembl chr14:96,156,494...96,196,253
|
|
G |
C3 |
complement C3 |
|
ISO |
protein:increased activity:pleural cavity |
RGD |
PMID:18256172 |
RGD:5129520 |
NCBI chr19:5,708,211...5,753,178
Ensembl chr19:6,629,287...6,674,699
|
|
G |
CAT |
catalase |
|
ISO |
|
RGD |
PMID:19778612 |
RGD:5130749 |
NCBI chr11:34,413,253...34,446,831
Ensembl chr11:34,289,603...34,323,160
|
|
G |
CCL25 |
C-C motif chemokine ligand 25 |
|
ISO |
protein:increased expression:pleural fluid |
RGD |
PMID:18056919 |
RGD:5130924 |
NCBI chr19:7,307,109...7,363,983
Ensembl chr19:8,208,273...8,217,780
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein:increased secretion:lung (mouse) |
RGD |
PMID:18672096 |
RGD:4890016 |
NCBI chr17:20,915,198...20,923,530
Ensembl chr17:21,210,798...21,219,172
|
|
G |
CCR3 |
C-C motif chemokine receptor 3 |
|
ISO |
associated with Mycobacterium Infections |
RGD |
PMID:17158890 |
RGD:4145643 |
NCBI chr 3:46,147,928...46,172,947
Ensembl chr 3:47,253,878...47,278,630
|
|
G |
CSF3 |
colony stimulating factor 3 |
|
ISO |
|
RGD |
PMID:8841835 |
RGD:11039424 |
NCBI chr17:17,271,074...17,273,493
Ensembl chr17:17,491,276...17,493,729
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
|
RGD |
PMID:14527170 |
RGD:5135449 |
NCBI chr 4:48,182,355...48,184,733
Ensembl chr 4:54,020,204...54,022,606
|
|
G |
CXCL9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
|
RGD |
PMID:14527170 |
RGD:5135449 |
NCBI chr 4:48,198,478...48,204,658
Ensembl chr 4:54,036,342...54,042,502
|
|
G |
EDNRA |
endothelin receptor type A |
|
ISO |
|
RGD |
PMID:15107459 |
RGD:4892325 |
NCBI chr 4:139,815,336...139,879,600
Ensembl chr 4:151,476,356...151,536,497
|
|
G |
ELANE |
elastase, neutrophil expressed |
|
ISO |
|
RGD |
PMID:20860667 |
RGD:10450565 |
NCBI chr19:276,499...280,598
|
|
G |
ESR1 |
estrogen receptor 1 |
|
ISO |
|
RGD |
PMID:17035596 |
RGD:4892303 |
NCBI chr 6:149,507,599...149,918,523
Ensembl chr 6:154,317,002...154,631,551
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism associated with Tuberculosis; protein:increased expression:pleural fluid, natural killer cell (human) protein:increased expression:bronchial epithelium (mouse) |
CTD RGD |
PMID:11181422 PMID:19056932 PMID:19714575 |
RGD:4145510 RGD:4145519 |
NCBI chr19:9,821,402...9,837,021
Ensembl chr19:10,484,414...10,500,605
|
|
G |
IL10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11181422 |
|
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
|
|
G |
IL15 |
interleukin 15 |
|
ISO |
|
RGD |
PMID:10823416 |
RGD:4990464 |
NCBI chr 4:133,693,995...134,115,470
Ensembl chr 4:145,402,111...145,416,622
|
|
G |
IL17A |
interleukin 17A |
treatment |
ISO |
|
RGD |
PMID:21898269 |
RGD:7175307 |
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
|
|
G |
IL1B |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:lung protein:increased expression:pleural cavity, exudate (rat) |
RGD CTD |
PMID:11181422 PMID:20141620 PMID:20175894 PMID:21898269 |
RGD:4142808 RGD:4142826 RGD:7175307 |
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
|
RGD |
PMID:8491511 |
RGD:4143233 |
NCBI chr2A:88,991,646...89,008,013
Ensembl chr2A:114,061,182...114,078,839
|
|
G |
IL6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11181422 |
|
NCBI chr 7:23,415,922...23,420,767
|
|
G |
LOC100974886 |
uncharacterized LOC100974886 |
|
ISO |
|
RGD |
PMID:14527170 PMID:21549112 |
RGD:5135064 RGD:5135449 |
NCBI chr 4:50,092,989...50,095,541
Ensembl chr 4:55,925,562...55,986,555
|
|
G |
LOC100976904 |
growth-regulated alpha protein |
|
ISO |
|
RGD |
PMID:14527170 |
RGD:5135449 |
NCBI chr 4:50,325,248...50,327,165
Ensembl chr 4:56,153,899...56,159,474
|
|
G |
MPO |
myeloperoxidase |
|
ISO |
protein:increased activity:lung |
RGD |
PMID:11577999 |
RGD:5130991 |
NCBI chr17:52,333,882...52,357,838
Ensembl chr17:57,201,073...57,212,111
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
|
ISO |
|
RGD |
PMID:14673141 |
RGD:6893408 |
NCBI chr2B:64,509,446...64,544,600
Ensembl chr2B:182,214,116...182,248,085
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased expression:pleural cavity (rat) |
RGD |
PMID:20141620 PMID:21898269 |
RGD:4142808 RGD:7175307 |
NCBI chr17:28,984,295...29,021,516
Ensembl chr17:29,471,510...29,617,093
|
|
G |
PLA2G6 |
phospholipase A2 group VI |
|
ISO |
|
RGD |
PMID:15003994 |
RGD:6482741 |
NCBI chr22:18,998,060...19,094,507
Ensembl chr22:36,849,794...36,919,509 Ensembl chr22:36,849,794...36,919,509
|
|
G |
PTAFR |
platelet activating factor receptor |
treatment |
ISO |
|
RGD |
PMID:8395390 |
RGD:10043147 |
NCBI chr 1:27,405,880...27,436,184
Ensembl chr 1:28,447,833...28,448,861
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
|
RGD |
PMID:15740981 PMID:20141620 |
RGD:4142808 RGD:5143929 |
NCBI chr 1:162,205,534...162,214,130
Ensembl chr 1:166,355,845...166,364,519
|
|
G |
SELP |
selectin P |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:lung |
CTD RGD |
PMID:11181422 PMID:21147071 |
RGD:6219005 |
NCBI chr 1:145,071,094...145,112,851
Ensembl chr 1:148,793,677...148,834,701
|
|
G |
SERPINE1 |
serpin family E member 1 |
susceptibility |
ISO |
associated with Familial Mediterranean Fever;DNA: DNA:polymorphism:promoter:rs1799768 (human): |
RGD |
PMID:23052617 |
RGD:13207414 |
NCBI chr 7:93,267,517...93,279,728
Ensembl chr 7:106,510,130...106,518,450
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:11161459 PMID:11181422 PMID:20141620 |
RGD:4142808 RGD:4143474 |
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
|
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
|
ISO |
|
RGD |
PMID:12773506 |
RGD:4890419 |
NCBI chr10:42,461,398...42,531,576
Ensembl chr10:45,639,946...45,710,016
|
|
|
G |
AICDA |
activation induced cytidine deaminase |
|
ISO |
|
RGD |
PMID:26456931 |
RGD:11098923 |
NCBI chr12:8,688,392...8,699,008
Ensembl chr12:8,904,273...8,913,917
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
|
ISO |
|
RGD |
PMID:20231413 |
RGD:4890435 |
NCBI chr10:42,461,398...42,531,576
Ensembl chr10:45,639,946...45,710,016
|
|
G |
BTK |
Bruton tyrosine kinase |
ameliorates |
ISO |
|
RGD |
PMID:30646846 |
RGD:124715470 |
NCBI chr X:90,551,874...90,588,786
Ensembl chr X:100,684,017...100,725,187
|
|
G |
C3 |
complement C3 |
disease_progression |
ISO |
associated with Liver Cirrhosis, Experimental;protein:decreased expression:respiratory system fluid/secretion protein:decreased expression:serum |
RGD |
PMID:20405 PMID:15972516 PMID:17956621 |
RGD:5129509 RGD:5129523 RGD:5130163 |
NCBI chr19:5,708,211...5,753,178
Ensembl chr19:6,629,287...6,674,699
|
|
G |
C5 |
complement C5 |
severity |
ISO |
|
RGD |
PMID:7814608 |
RGD:5130159 |
NCBI chr 9:92,069,574...92,202,513
Ensembl chr 9:120,426,354...120,523,856
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
susceptibility |
ISO |
|
RGD |
PMID:16455992 |
RGD:4892130 |
NCBI chr17:20,915,198...20,923,530
Ensembl chr17:21,210,798...21,219,172
|
|
G |
CD14 |
CD14 molecule |
|
ISO |
|
RGD |
PMID:17185649 |
RGD:4144788 |
NCBI chr 5:135,996,265...135,997,909
Ensembl chr 5:142,113,082...142,118,966
|
|
G |
CHI3L1 |
chitinase 3 like 1 |
|
ISO |
protein:increased secretion:serum (human) |
RGD |
PMID:10515841 |
RGD:4892626 |
NCBI chr 1:178,778,081...178,789,704
Ensembl chr 1:183,075,312...183,083,229
|
|
G |
CRHR1 |
corticotropin releasing hormone receptor 1 |
|
ISO |
|
RGD |
PMID:21774994 |
RGD:5147472 |
NCBI chr17:11,261,435...11,313,630
Ensembl chr17:11,650,057...11,701,208
|
|
G |
CRHR2 |
corticotropin releasing hormone receptor 2 |
|
ISO |
|
RGD |
PMID:21774994 |
RGD:5147472 |
NCBI chr 7:31,265,619...31,313,902
Ensembl chr 7:31,386,026...31,434,220
|
|
G |
CRP |
C-reactive protein |
disease_progression |
ISO |
|
RGD |
PMID:21281676 |
RGD:5131293 |
NCBI chr 1:135,062,102...135,064,402
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
NCBI chr 4:50,452,857...50,456,015
Ensembl chr 4:56,286,708...56,288,083
|
|
G |
CXCL9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:20381636 |
RGD:5135285 |
NCBI chr 4:48,198,478...48,204,658
Ensembl chr 4:54,036,342...54,042,502
|
|
G |
HMOX1 |
heme oxygenase 1 |
|
ISO |
associated with influenza;protein:increased expression:lung |
RGD |
PMID:17348295 |
RGD:4145366 |
NCBI chr22:16,388,368...16,401,289
Ensembl chr22:34,230,825...34,244,063
|
|
G |
IL15 |
interleukin 15 |
|
ISO |
protein:increased expression:alveolar macrophage, bronchial epithelial cell |
RGD |
PMID:17611121 |
RGD:5000755 |
NCBI chr 4:133,693,995...134,115,470
Ensembl chr 4:145,402,111...145,416,622
|
|
G |
IL15RA |
interleukin 15 receptor subunit alpha |
|
ISO |
|
RGD |
PMID:17611121 |
RGD:5000755 |
NCBI chr10:5,993,583...6,019,967
|
|
G |
IL17A |
interleukin 17A |
|
ISO |
|
RGD |
PMID:19995896 |
RGD:4888531 |
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
|
|
G |
IL18 |
interleukin 18 |
|
ISO |
|
RGD |
PMID:15770015 |
RGD:4889960 |
NCBI chr11:107,024,376...107,045,194
Ensembl chr11:110,867,586...110,888,371
|
|
G |
IL6 |
interleukin 6 |
|
ISO |
|
RGD |
PMID:20643849 |
RGD:4143255 |
NCBI chr 7:23,415,922...23,420,767
|
|
G |
LEP |
leptin |
|
ISO |
|
RGD |
PMID:17822444 |
RGD:5128869 |
NCBI chr 7:120,230,896...120,248,602
Ensembl chr 7:132,885,011...132,901,519
|
|
G |
LEPR |
leptin receptor |
|
ISO |
|
RGD |
PMID:21148797 |
RGD:5128846 |
NCBI chr 1:64,772,612...64,881,886
Ensembl chr 1:66,693,926...66,764,768
|
|
G |
LOC100976904 |
growth-regulated alpha protein |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:20958976 |
RGD:5134957 |
NCBI chr 4:50,325,248...50,327,165
Ensembl chr 4:56,153,899...56,159,474
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
NCBI chr22:3,883,119...3,990,368
Ensembl chr22:20,365,487...20,450,335
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
Ensembl chr16:30,489,362...30,498,017
|
|
G |
MASP2 |
MBL associated serine protease 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12904520 |
|
NCBI chr 1:9,787,565...9,810,276
Ensembl chr 1:11,009,760...11,030,734
|
|
G |
MBL2 |
mannose binding lectin 2 |
no_association |
ISO |
DNA:polymorphisms:5' utr, exon:multiple (human) DNA:mutations:5' utr, exon:multiple (human) |
RGD |
PMID:12047967 PMID:18641104 |
RGD:4889477 RGD:4889478 |
NCBI chr10:49,401,364...49,409,328
Ensembl chr10:51,527,758...51,543,432
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
|
RGD |
PMID:17056580 |
RGD:4891950 |
NCBI chr17:28,984,295...29,021,516
Ensembl chr17:29,471,510...29,617,093
|
|
G |
PTEN |
phosphatase and tensin homolog |
ameliorates |
ISO |
myeloid knockout |
RGD |
PMID:20505137 |
RGD:127285597 |
NCBI chr10:84,587,841...84,689,043
Ensembl chr10:88,093,539...88,194,605
|
|
G |
SFTPD |
surfactant protein D |
severity |
ISO |
|
RGD |
PMID:16255775 |
RGD:4143519 |
NCBI chr10:76,275,147...76,318,952
Ensembl chr10:78,965,252...78,974,181
|
|
G |
SIRT1 |
sirtuin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
NCBI chr10:64,368,878...64,401,684
Ensembl chr10:66,681,598...66,715,069
|
|
G |
STING1 |
stimulator of interferon response cGAMP interactor 1 |
|
ISO |
|
RGD |
PMID:29263110 |
RGD:39128230 |
NCBI chr 5:134,845,689...134,852,938
Ensembl chr 5:140,967,399...140,973,846
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
|
RGD |
PMID:19956717 |
RGD:4145321 |
NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
associated with influenza;protein:increased expression:lung |
RGD |
PMID:9032201 PMID:17348295 |
RGD:4143479 RGD:4145366 |
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
|
|
G |
TREM1 |
triggering receptor expressed on myeloid cells 1 |
ameliorates |
ISO |
|
RGD |
PMID:19596984 PMID:24752755 |
RGD:126928121 RGD:127229903 |
NCBI chr 6:40,861,283...40,874,446
Ensembl chr 6:42,163,337...42,183,091
|
|
|
G |
AZIN1 |
antizyme inhibitor 1 |
|
ISO |
mRNA:increased expression:alveolar macrophage |
RGD |
PMID:19158080 |
RGD:14700806 |
NCBI chr 8:99,483,027...99,521,151
Ensembl chr 8:101,639,950...101,678,604
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:17169032 |
RGD:5129525 |
NCBI chr19:5,708,211...5,753,178
Ensembl chr19:6,629,287...6,674,699
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:20618689 |
RGD:4891428 |
NCBI chr17:22,528,154...22,530,091
Ensembl chr17:22,820,890...22,823,384
|
|
G |
CD40 |
CD40 molecule |
treatment |
ISO |
|
RGD |
PMID:10968950 |
RGD:8547797 |
NCBI chr20:42,455,711...42,467,139
Ensembl chr20:43,541,619...43,552,994
|
|
G |
CSF2 |
colony stimulating factor 2 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:19487471 |
RGD:5131475 |
NCBI chr 5:127,496,951...127,499,325
Ensembl chr 5:133,660,775...133,663,146
|
|
G |
IL23A |
interleukin 23 subunit alpha |
|
ISO |
|
RGD |
PMID:17403873 |
RGD:39458043 |
NCBI chr12:32,575,321...32,576,856
Ensembl chr12:32,828,902...32,830,617
|
|
G |
IL33 |
interleukin 33 |
treatment |
ISO |
|
RGD |
PMID:21220696 |
RGD:40400892 |
NCBI chr 9:6,027,014...6,069,540
Ensembl chr 9:6,234,178...6,248,624
|
|
G |
LOC100972994 |
HLA class II histocompatibility antigen, DQ beta 1 chain |
|
ISO |
|
RGD |
PMID:20377877 |
RGD:4144112 |
NCBI chr 6:32,237,395...32,244,201
Ensembl chr 6:33,353,599...33,360,272
|
|
G |
LOC103783265 |
pulmonary surfactant-associated protein A1 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11385364 |
RGD:4143431 |
NCBI chr10:76,571,312...76,575,820
|
|
G |
MUC1 |
mucin 1, cell surface associated |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:9617869 |
RGD:5131424 |
NCBI chr 1:130,533,508...130,537,866
Ensembl chr 1:134,141,969...134,145,850
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
protein:decreased dimerization:alveolar macrophage mRNA:increased expression:alveolar macrophage |
RGD |
PMID:20377877 PMID:20558778 |
RGD:4144112 RGD:4891486 |
NCBI chr17:28,984,295...29,021,516
Ensembl chr17:29,471,510...29,617,093
|
|
G |
SFTPB |
surfactant protein B |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:11385364 |
RGD:4143431 |
NCBI chr2A:85,708,485...85,718,120
Ensembl chr2A:87,257,244...87,268,332
|
|
G |
SFTPC |
surfactant protein C |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:11385364 |
RGD:4143431 |
NCBI chr 8:21,402,060...21,409,438
Ensembl chr 8:18,345,940...18,348,764
|
|
G |
SFTPD |
surfactant protein D |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11385364 |
RGD:4143431 |
NCBI chr10:76,275,147...76,318,952
Ensembl chr10:78,965,252...78,974,181
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
|
RGD |
PMID:18400546 |
RGD:4145341 |
NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331
|
|
|
G |
ABCF1 |
ATP binding cassette subfamily F member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 6:30,314,216...30,333,912
Ensembl chr 6:31,184,831...31,203,059
|
|
G |
ABO |
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase |
severity |
ISO |
DNA:polymorphism:cds:allele A (human) |
RGD |
PMID:4375858 |
RGD:39938844 |
NCBI chr 9:104,354,115...104,399,057
Ensembl chr 9:132,989,574...133,010,324
|
|
G |
ACE |
angiotensin I converting enzyme |
disease_progression |
ISO |
associated with Hypertension |
RGD |
PMID:17727310 PMID:19455553 PMID:20051911 |
RGD:4140916 RGD:4140918 RGD:4140922 |
NCBI chr17:57,556,294...57,577,294
Ensembl chr17:62,702,341...62,733,853
|
|
G |
ADORA1 |
adenosine A1 receptor |
|
ISO |
|
RGD |
PMID:15630442 |
RGD:5129098 |
NCBI chr 1:178,728,751...178,769,066
Ensembl chr 1:183,023,466...183,063,760
|
|
G |
ADORA2A |
adenosine A2a receptor |
|
ISO |
associated with Anemia, Sickle Cell associated with Lung Injury |
RGD |
PMID:17601796 PMID:18703794 PMID:20798237 |
RGD:4890358 RGD:4890364 RGD:4890376 |
NCBI chr22:5,233,876...5,248,622
Ensembl chr22:22,104,253...22,114,189
|
|
G |
ADRB2 |
adrenoceptor beta 2 |
|
ISO |
|
RGD |
PMID:19925785 |
RGD:4145041 |
NCBI chr 5:144,259,756...144,398,421
Ensembl chr 5:150,267,554...150,315,892
|
|
G |
AGT |
angiotensinogen |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:28960804 |
|
NCBI chr 1:206,252,141...206,263,830
Ensembl chr 1:211,279,015...211,291,044
|
|
G |
AHR |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23337360 |
|
NCBI chr 7:17,949,254...17,998,737
Ensembl chr 7:17,278,637...17,326,171
|
|
G |
ALB |
albumin |
disease_progression |
ISO |
|
RGD |
PMID:23286966 |
RGD:11035283 |
NCBI chr 4:50,773,244...50,790,474
Ensembl chr 4:56,605,322...56,622,418
|
|
G |
BDKRB2 |
bradykinin receptor B2 |
|
ISO |
|
RGD |
PMID:15021973 |
RGD:4891030 |
NCBI chr14:76,832,833...76,873,860
Ensembl chr14:96,156,494...96,196,253
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:10886251 |
RGD:5129562 |
NCBI chr19:5,708,211...5,753,178
Ensembl chr19:6,629,287...6,674,699
|
|
G |
C3AR1 |
complement C3a receptor 1 |
|
ISO |
associated with Respiratory Syncytial Virus Infections |
RGD |
PMID:17079327 |
RGD:5129688 |
NCBI chr12:8,178,064...8,186,206
Ensembl chr12:8,220,933...8,222,381
|
|
G |
C5 |
complement C5 |
|
ISO |
associated with Respiratory Syncytial Virus Infections |
RGD |
PMID:3631740 PMID:17079327 |
RGD:5129688 RGD:5130161 |
NCBI chr 9:92,069,574...92,202,513
Ensembl chr 9:120,426,354...120,523,856
|
|
G |
CASP1 |
caspase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr11:99,965,964...99,975,640
Ensembl chr11:103,448,497...103,458,149 Ensembl chr11:103,448,497...103,458,149
|
|
G |
CCL13 |
C-C motif chemokine ligand 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr17:22,430,633...22,432,893
Ensembl chr17:22,723,888...22,726,381
|
|
G |
CCL17 |
C-C motif chemokine ligand 17 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:lung |
CTD RGD |
PMID:15993846 PMID:21625544 |
RGD:2306304 |
NCBI chr16:37,678,518...37,689,350
Ensembl chr16:56,819,949...56,822,131
|
|
G |
CCL19 |
C-C motif chemokine ligand 19 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 9:34,525,820...34,527,628
Ensembl chr 9:35,334,353...35,336,108
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19648283 PMID:21625544 |
RGD:4891461 |
NCBI chr17:22,528,154...22,530,091
Ensembl chr17:22,820,890...22,823,384
|
|
G |
CCL20 |
C-C motif chemokine ligand 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr2B:115,052,768...115,056,479
Ensembl chr2B:233,862,505...233,866,225
|
|
G |
CCL22 |
C-C motif chemokine ligand 22 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:15993846 |
RGD:2306304 |
NCBI chr16:37,631,861...37,640,208
Ensembl chr16:56,765,367...56,771,213
|
|
G |
CCL23 |
C-C motif chemokine ligand 23 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr17:20,778,008...20,782,929
Ensembl chr17:21,073,882...21,078,794
|
|
G |
CCL24 |
C-C motif chemokine ligand 24 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 7:68,206,688...68,210,343
Ensembl chr 7:82,263,310...82,265,480
|
|
G |
CCL8 |
C-C motif chemokine ligand 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr17:22,468,080...22,470,443
Ensembl chr17:22,761,064...22,763,933
|
|
G |
CCR1 |
C-C motif chemokine receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:20870892 PMID:21625544 |
RGD:5688175 |
NCBI chr 3:46,107,526...46,114,229
Ensembl chr 3:47,214,688...47,215,755
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:14615370 PMID:17284325 PMID:21625544 |
RGD:4145068 RGD:8661704 |
NCBI chr 3:46,255,725...46,263,285
Ensembl chr 3:47,361,124...47,368,312
|
|
G |
CCR3 |
C-C motif chemokine receptor 3 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:19762220 |
RGD:4145622 |
NCBI chr 3:46,147,928...46,172,947
Ensembl chr 3:47,253,878...47,278,630
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
|
ISO |
Idiopathic Pneumonia Syndrome; mRNA:increased expression:lung (mouse) |
RGD |
PMID:15546955 |
RGD:4892103 |
NCBI chr 3:46,273,096...46,278,471
Ensembl chr 3:47,380,321...47,381,379
|
|
G |
CCR6 |
C-C motif chemokine receptor 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 6:165,094,563...165,109,774
Ensembl chr 6:170,069,689...170,084,779
|
|
G |
CCR7 |
C-C motif chemokine receptor 7 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:16394278 |
RGD:5130919 |
NCBI chr17:16,720,236...16,731,955
Ensembl chr17:16,949,119...16,956,370
|
|
G |
CCR9 |
C-C motif chemokine receptor 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 3:45,719,655...45,810,964
Ensembl chr 3:46,900,845...46,917,443
|
|
G |
CD14 |
CD14 molecule |
|
ISO |
protein:increased expression:multiple |
RGD |
PMID:20302606 |
RGD:4144794 |
NCBI chr 5:135,996,265...135,997,909
Ensembl chr 5:142,113,082...142,118,966
|
|
G |
CD163 |
CD163 molecule |
|
ISO |
associated with liver disease;protein:increased expression:blood serum (human) |
RGD |
PMID:26339412 |
RGD:11251207 |
NCBI chr12:7,616,714...7,649,768
Ensembl chr12:7,775,343...7,810,023
|
|
G |
CD40LG |
CD40 ligand |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr X:125,776,138...125,788,820
Ensembl chr X:136,042,849...136,058,202
|
|
G |
COQ6 |
coenzyme Q6, monooxygenase |
|
ISO |
ClinVar Annotator: match by term: increased susceptibility to pneumonia |
ClinVar |
|
|
NCBI chr14:54,509,514...54,522,310
Ensembl chr14:73,363,711...73,376,545
|
|
G |
CRHR2 |
corticotropin releasing hormone receptor 2 |
|
ISO |
|
RGD |
PMID:16855006 |
RGD:5130933 |
NCBI chr 7:31,265,619...31,313,902
Ensembl chr 7:31,386,026...31,434,220
|
|
G |
CRP |
C-reactive protein |
severity disease_progression |
ISO |
|
RGD |
PMID:21258955 PMID:21439658 |
RGD:5131283 RGD:5131291 |
NCBI chr 1:135,062,102...135,064,402
|
|
G |
CSF2 |
colony stimulating factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:11732872 PMID:19633061 |
RGD:4142837 |
NCBI chr 5:127,496,951...127,499,325
Ensembl chr 5:133,660,775...133,663,146
|
|
G |
CSF3R |
colony stimulating factor 3 receptor |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 1:35,730,678...35,747,939
Ensembl chr 1:36,897,153...36,910,612
|
|
G |
CSK |
C-terminal Src kinase |
|
ISO |
|
RGD |
PMID:14975240 |
RGD:5134363 |
NCBI chr15:53,724,814...53,745,710
Ensembl chr15:73,342,703...73,363,476
|
|
G |
CX3CL1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr16:37,646,447...37,659,078
Ensembl chr16:56,779,065...56,791,760
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
associated with Lupus Erythematosus, Systemic;mRNA:increased expression:lung |
RGD |
PMID:14979941 PMID:15265940 |
RGD:5135445 RGD:5135491 |
NCBI chr 4:48,182,355...48,184,733
Ensembl chr 4:54,020,204...54,022,606
|
|
G |
CXCL5 |
C-X-C motif chemokine ligand 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:sputum |
CTD RGD |
PMID:18410262 PMID:21625544 |
RGD:5135259 |
NCBI chr 4:50,192,665...50,195,642
Ensembl chr 4:56,024,848...56,027,989
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:bronchoalveolar lavage (human) |
CTD RGD |
PMID:21625544 PMID:32407669 |
RGD:30296672 |
NCBI chr 4:50,452,857...50,456,015
Ensembl chr 4:56,286,708...56,288,083
|
|
G |
CXCL9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
protein:increased expression:serum CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:15265940 PMID:17052299 PMID:21625544 |
RGD:5135440 RGD:5135445 |
NCBI chr 4:48,198,478...48,204,658
Ensembl chr 4:54,036,342...54,042,502
|
|
G |
CXCR2 |
C-X-C motif chemokine receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr2B:105,387,198...105,400,533
Ensembl chr2B:223,997,066...223,998,148
|
|
G |
CXCR3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
associated with Lupus Erythematosus, Systemic;mRNA:increased expression:lung CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:14979941 PMID:15265940 PMID:21625544 |
RGD:5135445 RGD:5135491 |
NCBI chr X:60,880,759...60,883,355
Ensembl chr X:70,933,160...70,935,756
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
susceptibility |
ISO |
DNA:polymorphism (human) |
RGD |
PMID:15928955 |
RGD:4142512 |
NCBI chr15:53,664,968...53,672,277
Ensembl chr15:73,284,566...73,290,636
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
|
ISO |
protein:increased expression:alveolus, epithelial cell DNA:polymorphism (human) |
RGD |
PMID:14698565 PMID:15928955 |
RGD:4142512 RGD:4892223 |
Ensembl chr10:134,839,025...134,852,719
|
|
G |
DEFB1 |
defensin beta 1 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:17000097 |
RGD:4892262 |
NCBI chr 8:403,268...410,712
Ensembl chr 8:6,874,235...6,881,631
|
|
G |
EDN1 |
endothelin 1 |
severity |
ISO |
protein:increased secretion:plasma (human) |
RGD |
PMID:20529344 |
RGD:4144879 |
NCBI chr 6:12,076,312...12,142,861
Ensembl chr 6:12,462,718...12,503,545
|
|
G |
EGF |
epidermal growth factor |
resistance |
ISO |
|
RGD |
PMID:21701422 |
RGD:6906904 |
NCBI chr 4:102,410,724...102,509,691
Ensembl chr 4:112,977,565...113,076,460
|
|
G |
EGR1 |
early growth response 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29787794 |
|
NCBI chr 5:133,845,305...133,849,291
Ensembl chr 5:139,975,635...139,979,260
|
|
G |
ENTPD5 |
ectonucleoside triphosphate diphosphohydrolase 5 (inactive) |
|
ISO |
ClinVar Annotator: match by term: increased susceptibility to pneumonia |
ClinVar |
|
|
NCBI chr14:54,522,428...54,578,501
Ensembl chr14:73,376,684...73,410,468
|
|
G |
FCGR3A |
Fc gamma receptor IIIa |
treatment |
ISO |
associated with Hodgkin Disease;DNA:SNP:exon:p.F158V (rs396991) (human) |
RGD |
PMID:20423913 |
RGD:11352258 |
NCBI chr 1:137,027,943...137,036,738
|
|
G |
GRP |
gastrin releasing peptide |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:30146822 |
RGD:401700396 |
NCBI chr18:52,614,169...52,626,427
Ensembl chr18:55,942,263...55,953,188
|
|
G |
HDC |
histidine decarboxylase |
|
ISO |
|
RGD |
PMID:14556983 |
RGD:5143922 |
NCBI chr15:29,188,296...29,212,327
Ensembl chr15:47,510,629...47,534,577
|
|
G |
HMOX1 |
heme oxygenase 1 |
susceptibility |
ISO |
DNA:allele:promoter:L allele of the (GT)n repeat (>30 repeats) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:16582079 |
RGD:1601608 |
NCBI chr22:16,388,368...16,401,289
Ensembl chr22:34,230,825...34,244,063
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
treatment |
ISO |
associated with Reperfusion Injury |
RGD |
PMID:22882462 |
RGD:8547727 |
NCBI chr19:9,821,402...9,837,021
Ensembl chr19:10,484,414...10,500,605
|
|
G |
IFNAR1 |
interferon alpha and beta receptor subunit 1 |
resistance |
ISO |
Cryptococcus (yeast) pneumonia |
RGD |
PMID:18566423 |
RGD:5490275 |
NCBI chr21:19,683,496...19,719,034
Ensembl chr21:33,058,396...33,093,824
|
|
G |
IFNG |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
|
|
G |
IKBKB |
inhibitor of nuclear factor kappa B kinase subunit beta |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:20080200 PMID:31095431 |
RGD:7495767 |
NCBI chr 8:41,515,613...41,576,229
Ensembl chr 8:38,960,594...39,020,971
|
|
G |
IL10 |
interleukin 10 |
disease_progression |
ISO |
protein:increased expression:blood |
RGD |
PMID:20595152 |
RGD:4140400 |
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
associated with Respiratory Distress Syndrome, Newborn; protein:increased expression:bronchoalveolar lavage fluid CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19695190 PMID:21625544 |
RGD:4145774 |
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
|
|
G |
IL13RA2 |
interleukin 13 receptor subunit alpha 2 |
|
ISO |
mRNA:increased expression:lung, fibroblast |
RGD |
PMID:15161635 |
RGD:4890021 |
NCBI chr X:104,092,993...104,146,062
Ensembl chr X:114,597,077...114,635,253
|
|
G |
IL17A |
interleukin 17A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20498020 PMID:21625544 PMID:22848348 |
RGD:4888524 RGD:9068417 |
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
|
|
G |
IL18 |
interleukin 18 |
|
ISO |
associated with reperfusion injury mRNA, protein:increased expression:lung,bronchoalveolar fluid CTD Direct Evidence: marker/mechanism protein:increased expression:serum |
RGD CTD |
PMID:11739527 PMID:15955140 PMID:16052682 PMID:17400729 PMID:21625544 |
RGD:4889590 RGD:4889825 RGD:4889836 RGD:729357 |
NCBI chr11:107,024,376...107,045,194
Ensembl chr11:110,867,586...110,888,371
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:8806881 |
RGD:7794765 |
NCBI chr2A:89,273,482...89,284,421
Ensembl chr2A:113,784,854...113,795,801
|
|
G |
IL1B |
interleukin 1 beta |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:lung mRNA:increased expression:lung |
RGD CTD |
PMID:19825784 PMID:19901996 PMID:20007584 PMID:20155581 PMID:20476872 PMID:21625544 PMID:32407669 More...
|
RGD:30296672 RGD:4142536 RGD:4142812 RGD:4142827 RGD:4142831 RGD:4143211 |
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
|
|
G |
IL1R1 |
interleukin 1 receptor type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
| |